ORAU TEAM

Dose Reconstruction

Project for NIOSH

Oak Ridge Associated Universities I Dade Moeller I MJW Technical Services

Page 1 of 42

DOE Review Release 01/10/2013

Document Title:

Internal Dosimetry Organ, External 

Dosimetry Organ, and IREP Model Selection 

by ICD-9 Code

Document Number: ORAUT-OTIB-0005

Revision: 05

Effective Date: 12/20/2012

Type of Document: OTIB

Supersedes: Revision 04

Subject Expert(s): Scott R. Siebert

Approval: Signature on File Concurrence Date: 12/19/2012

Edward F. Maher, Document Owner

Concurrence: Vickie S. Short Signature on File for Concurrence Date: 12/20/2012

Kate Kimpan, Project Director

Approval: Signature on File Approval Date: 12/20/2012

James W. Neton, Associate Director for Science

New Total Rewrite Revision Page Change

FOR DOCUMENTS MARKED AS A TOTAL REWRITE, REVISION, OR PAGE CHANGE, REPLACE THE PRIOR 

REVISION AND DISCARD / DESTROY ALL COPIES OF THE PRIOR REVISION.
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 2 of 42

PUBLICATION RECORD

EFFECTIVE 

DATE

REVISION 

NUMBER DESCRIPTION

11/03/2003 00 ORAU technical information bulletin to clarify IMBA organ and IREP 

model selection First approved issue. Initiated by Elizabeth M. 

Brackett.

01/23/2004 01 Incorporates applicable external dosimetry organ selection. 

Approved issue of Revision 01. Initiated by Elizabeth M. Brackett.

03/05/2004 01 PC-1 IREP model correction for ICD-9 code 238.7 (added Bone model), 

remove IMBA/External/IREP model info from header rows for ICD-9 

codes 194 and 205. Approved issue of page change 1. Initiated by 

Elizabeth M. Brackett. 

05/07/2004 01 PC-2 IMBA and External model correction for ICD-9 code 231.8 (changed 

to med review on page 15), IMBA model correction for ICD-9 codes 

235.8 and 235.9 (changed to med review on page 16), External 

model correction for ICD-9 code 185 (changed to bladder on page 8). 

Approved issue of page change 2. Initiated by Elizabeth M. Brackett. 

10/29/2004 01 PC-3 IMBA model correction for ICD-9 code 189.2, 189.3, and 189.4 

(changed to highest non-met organ/tissue on page 9), added 

footnote number 5 to Table 1 for ICD-9 code 232 on page 18. 

Changed DOL documentation to NIOSH Referral Summary 

Document (NRSD) on page 20. Approved issue of page change 3. 

Initiated by Scott R. Siebert. 

12/02/2005 02 Adds information for ICD-9 codes 289.7 and 289.9, clarifies handling 

adenocarcinoma of the distal (lower third) esophagus, corrects 

external organ for ICD-9 codes 233.4 and 236.5, updates correct 

model selections for various cancers (to reflect guidance in OCAS 

TIB-012, except as directed by OCAS to mark many 200-204 organs 

as “Reserved”), adds likely primary cancer selection for secondary 

cancers. Changes references to “IMBA organ” to “Internal Dosimetry 

organ.” Approved issue of Revision 02. Training required: As 

determined by the Task Manager. Initiated by Scott R. Siebert.

02/10/2006 02 PC-1 Approved page change revision. Updates Table 3-1 (pages 15 – 22) 

in Section 3.2 to reflect guidance in OCAS-TIB-012 Rev 1 (internal 

and external organs for ICD-9 series 200 through 204 changed from 

“Reserved” to the specified organ) and changes OCAS-TIB-012 

issue date and revision number in reference section (page 33). No 

sections were deleted. Training required: As determined by the 

Task Manager. Initiated by Scott R. Siebert. 

02/26/2010 03 Adds discussion of ICD-9 vs. ICD-9-CM in Background section, adds 

codes into Table 3-1 and 3-2 that cross-reference to ICD-9-CM 

codes, adds clarification for skin cancer codes, updates organ 

selection for ICD-9 codes 155 and 156, adds clarification that this 

OTIB is not applicable for x-ray procedures. No sections were 

deleted. Incorporates formal internal and NIOSH review comments. 

Constitutes a total rewrite of the document. Training required: As 

determined by the Objective Manager. Initiated by Scott R. Siebert.
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 3 of 42

04/18/2011 04 Changes external organ for ICD-9 codes 194.1 and 194.5 to Thyroid 

only (rather than Thyroid/Remainder), adds BCC as an IREP model 

option for ICD-9 code 232, changes internal organ from Medical 

Review to Skin for 238.2, add SCC as an IREP model option for 

238.2, updates footnote “e” to include ICD-9 code 238.2 and BCC, 

update the internal organ from “Medical Review” to a specific organ 

of interest for 236.91 (Kidney), 238.0 (Bone surface), 238.3 (Breast), 

239.2 (Bone surface or Skin depending on cancer type). Additional 

change to 238.0 and 239.2(bone) based on formal internal review 

comments – both changed to bone surface for internal and external 

organs. Additional change to add SCC as viable IREP model for 

239.2(skin) based on formal NIOSH review. Training required: As 

determined by the Objective Manager. Initiated by Scott R. Siebert. 

12/20/2012 05 Adds Chronic lymphocytic leukemia (CLL) as radiogenic cancer –

Section 4.11, Table 3-1 (ICD-9 code 204.1 series), footnote “d” to 

Table 3-1. Added clarification to Sec 4.9 on comparisons of ULI and 

LLI. Update Table 3-1 to add 5th digit in ICD-9 codes for 173, add 

clarification to Sec 4.7 for same. Update 150.1 and 150.9 to clarify 

that stomach is not appropriate for either code since location is either 

thoracic or unspecified and add discussion of “nec” and “nos” to Sec 

4.8. Added discussion of ICD-9 code 199 in Section 3.2. 

Incorporates formal internal and NIOSH review comments. Training 

required: As determined by the Objective Manager. Initiated by 

Scott R. Siebert. 
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 4 of 42

TABLE OF CONTENTS

SECTION TITLE PAGE

Acronyms and Abbreviations ...............................................................................................................5

1.0 Purpose ...................................................................................................................................6

2.0 Background..............................................................................................................................6

3.0 Guidance .................................................................................................................................7

3.1 Selection of Appropriate Organs, Tissues, and Models.................................................7

3.2 Secondary Cancers with Unknown Primary Cancer Site...............................................7

4.0 Discussion ...............................................................................................................................7

4.1 Highest NonMetabolic Organ........................................................................................7

4.2 Medical Review ............................................................................................................8

4.3 Thyroid or Remainder Selection for External Dose .......................................................8

4.4 Remainder Selection for External Dose ........................................................................8

4.5 Bladder.........................................................................................................................8

4.6 Multiple IREP Models ...................................................................................................8

4.7 Skin Cancer Model Clarification....................................................................................9

4.8 Adenocarcinoma of the Distal (Lower Third) Esophagus ..............................................9

4.9 Secondary Cancers – Likely Primary Cancer Sites with Multiple IMBA, 

External, and IREP Organ Model Options ..................................................................10

4.10 Multiple Secondary Cancers with Unknown Primary Cancer Site or Multiple 

Primary and Secondary Cancers ................................................................................11

4.11 Chronic Lymphocytic Leukemia..................................................................................11

References ........................................................................................................................................42

LIST OF TABLES

TABLE TITLE PAGE

3-1. Selection of organs, tissues, and IREP models for internal and external dose 

reconstruction based on ICD-9 code ...................................................................................... 12

3-2 Selection of primary cancer(s) from secondary cancer codes ................................................ 41
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 5 of 42

ACRONYMS AND ABBREVIATIONS

BB Bronchial region

CLL chronic lymphocytic leukemia

DHHS U.S. Department of Health and Human Services

DOL U.S. Department of Labor

EEOICPA Energy Employees Occupational Illness Compensation Program Act of 2000

ET1 Extrathoracic region 1

ET2 Extrathoracic region 2

ICD-9 The International Classification of Diseases, 9th Revision

ICD-9-CM The International Classification of Diseases, 9th Revision, Clinical Modification

ICRP International Commission on Radiological Protection

IMBA Integrated Modules for Bioassay Analysis

IREP Interactive RadioEpidemiological Program

LLI lower large intestine

LN(ET) Extrathoracic lymph nodes

LN(TH) Thoracic lymph nodes

NCHS National Center for Health Statistics

NEC Not Elsewhere Classified

NIOSH National Institute for Occupational Safety and Health

NOS Not Otherwise Specified

OCAS Office of Compensation Analysis and Support

ORAU Oak Ridge Associated Universities

POC probability of causation

SI small intestine

TIB technical information bulletin

ULI upper large intestine

U.S.C. United States Code

WHO World Health Organization

§ section or sections
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 6 of 42

1.0 PURPOSE

Technical information bulletins (TIBs) are not official determinations made by the National Institute for 

Occupational Safety and Health (NIOSH) but are rather general working documents that provide 

historical background information and guidance to assist in the preparation of dose reconstructions at 

particular sites or categories of sites. They will be revised in the event additional relevant information 

is obtained about the affected site(s). TIBs may be used to assist NIOSH staff in the completion of 

individual dose reconstructions. 

In this document, the word “facility” is used as a general term for an area, building, or group of 

buildings that served a specific purpose at a site. It does not necessarily connote an “atomic weapons 

employer facility” or a “Department of Energy (DOE) facility” as defined in the Energy Employees 

Occupational Illness Compensation Program Act of 2000 [42 U.S.C. § 7384l(5) and (12)].

This TIB provides guidance on selection of (1) the appropriate International Commission on 

Radiological Protection (ICRP) organ or tissue model to estimate the internal dose for specific codes

from the World Health Organization’s (WHO) International Classification of Diseases, Ninth Revision

(ICD-9; WHO 1977), (2) the appropriate organs or tissues to estimate external dose, and (3) the 

appropriate model in the Interactive RadioEpidemiological Program (IREP). This TIB also provides 

information for selecting and assessing likely primary cancers for secondary cancers.

This TIB does not address the appropriate organ to use with medical X-ray procedures due to 

different potential exposure geometries of those procedures. The organs to be used for dose 

reconstruction from medical X-ray procedures can be found in ORAUT-OTIB-0006, Dose 

Reconstruction from Occupationally Related Diagnostic X-Ray Procedures (ORAUT 2005), or the sitespecific technical basis documents and site profiles.

2.0 BACKGROUND

Under EEOICPA, the organs or tissues for which doses must be estimated are those that are 

delineated by the specified ICD-9 code that is received from the U.S. Department of Labor (DOL). 

While many ICD-9 codes are clear in their intended organ or tissue, additional guidance is necessary 

to identify the appropriate organs or tissues for internal and external dose estimation and the IREP 

model to use for the organ or tissue. This TIB designates the appropriate internal dosimetry organ

and tissue selection for the various ICD-9 coded cancers, the appropriate organs and tissues to 

estimate external dose, and the appropriate IREP model.

Coding of the cancers is conducted by DOL on the basis of ICD-9. The U.S. Department of Health 

and Human Services (DHHS) National Center for Health Statistics (NCHS) has issued a related 

document, International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM; 

DHHS 2008), which is widely used in the United States. ICD-9-CM is revised on an annual basis. 

Although the WHO has issued Revision 10 of the ICD, DHHS has not yet adopted it. Although the 

ICD-9-CM coding provides detail that is not in ICD-9, this has not historically been required for 

assessment under EEOICPA. However, because ICD-9-CM is widely used in the United States, DOL 

might provide some codes that did not appear in earlier versions of this TIB. NCHS provides a 

conversion table for translating a new code to its previous code (DHHS 2009). This table has been 

used to add codes to Tables 3-1 and 3-2, which appear after the text of this document. Due to the 

complexity of determining the appropriate organs for lymphatic/hematopoietic cancers, the NIOSH 

Division of Compensation Analysis and Support (previously the Office of Compensation Analysis and 

Support or OCAS) conducted a comprehensive review of the state of knowledge regarding the 

etiology and diagnosis of the various lymphomas, leukemias, and multiple myeloma. This TIB 

incorporates the findings from this review as set forth in OCAS-TIB-012, Selection for Internal and 

External Dosimetry Target Organs for Lymphatic/Hematopoietic Cancers (NIOSH 2006).
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 7 of 42

3.0 GUIDANCE

3.1 SELECTION OF APPROPRIATE ORGANS, TISSUES, AND MODELS

Table 3-1 correlates ICD-9 codes to the appropriate organ and tissue selection for internal and 

external dose estimation and to the appropriate IREP model. Organs and tissues that are labeled 

“Highest non-met org/tiss” indicate that dose to the highest nonmetabolic organ is to be used to 

represent the dose to the ICD-9 designated organ or tissue. A discussion of this term is included in 

Section 4.0. The remaining regions are described by the term in the Integrated Modules for Bioassay 

Analysis (IMBA) software program.

3.2 SECONDARY CANCERS WITH UNKNOWN PRIMARY CANCER SITE

Another situation that needs to be assessed is the diagnosis of a secondary cancer with an unknown 

primary cancer location. It is accepted in medicine that cancer-causing agents such as ionizing 

radiation produce primary cancers. This means, for a case in which the primary site of cancer is 

unknown, that the primary site must be established by inference to establish the probability of 

causation (POC). For each secondary cancer, the set of primary cancers that produced 

approximately 75% of that secondary cancer among the U.S. population was identified (males and 

females were considered separately). Therefore, for secondary cancers with unknown primary sites,

Table 3-2 should be consulted to select likely primary sites, which should then be evaluated using

IREP (reproduced from Table 7 in the IREP technical documentation).

Because each secondary cancer in Table 3-2 has more than one likely primary cancer site, each likely 

primary site must be evaluated using IREP to determine a POC. If one of the likely primary cancer 

sites yields a POC greater than or equal to 50%, this site should be assumed to be the originating site 

for the secondary cancer and should be submitted as such.

If none of the likely primary cancer sites yields a POC greater than or equal to 50%, the supporting 

documentation for all of them should be submitted, demonstrating that all were less than 50%.

ICD-9 code 199 and its extensions present an unusual case since this can be coded by DOL as either 

a primary or a secondary cancer. In either case, the location is either unknown or not clearly defined. 

If coded as a secondary cancer, this means both the secondary cancer as well as the primary cancer 

that caused it are unknown. Since this information is unknown, assess this ICD-9 code as outlined in 

Table 3-1 regardless of suggestions from DOL on likely primary locations.

4.0 DISCUSSION

4.1 HIGHEST NONMETABOLIC ORGAN

The dose estimate for a number of tissues is based on the highest nonmetabolic organ dose, which is 

designated as “Highest non-met org/tiss” in the table. Metabolic organs are those that are specifically 

modeled by the ICRP for a particular element. The biokinetic models are based on the behavior of 

the particular element in the body, so the metabolic organs vary with the element of interest. The 

metabolic organs include the gastrointestinal tract from ICRP Publication 30 (ICRP 1979) and, in the 

case of inhalation, the respiratory tract from ICRP Publication 66 (ICRP 1994).

For radionuclides that primarily emit alpha or beta radiation, the soft tissue compartment becomes the 

primary recipient of dose. This compartment contains all the organs that are not specifically 

accounted for in the metabolic model. This compartment accounts for the dose that is delivered by 

material that is actually deposited in that tissue. An additional source of exposure to the tissue is 
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 8 of 42

known as photon cross-irradiation. Cross-irradiation is the exposure to a tissue from photons that 

originate in other tissues.

When the energy that is emitted by a radionuclide is primarily alpha or beta radiation, the soft tissue 

compartment becomes the primary source of dose. Under this scenario most of the nonmetabolic 

organs receive the same dose. For radionuclides for which photon emissions are a major source of 

energy emitted, the nonmetabolic organ doses can vary due to their relative proximity to the metabolic 

organs in which the radionuclides concentrate. IMBA calculates the dose from both sources of 

irradiation and sums them. For many radionuclides (predominately alpha and beta emitters), this 

causes only minor differences in doses to nonmetabolic organs, so choosing the highest is a realistic 

assumption with only minor (if any) overestimation.

It is conceivable that a situation could arise in which a photon-emitting radionuclide causes a large 

difference in doses that are delivered to nonmetabolic organs. In accordance with OCAS-IG-002, 

Internal Dose Reconstruction Implementation Guideline (NIOSH 2002), it is acceptable in these 

situations to base the dose on an organ that is not the highest nonmetabolic organ. The choice in 

these cases should be based on the proximity of the model organ to the actual organ of interest.

4.2 MEDICAL REVIEW

Due to the complexity of determining the appropriate organs and tissues for some ICD-9 code 

cancers, a medical review by an Oak Ridge Associated Universities (ORAU) Team physician is 

required to determine the organs and tissues to use in IMBA for those cancers. These cancers have 

been designated in Table 3-1 as “Medical review.” The ORAU Team physician will recommend to the 

dose reconstructor the appropriate organs and tissues for dose estimation purposes.

4.3 THYROID OR REMAINDER SELECTION FOR EXTERNAL DOSE

For cancer sites for which Table 3-1 lists “Thyroid/Remainder” for the external organ selection, there 

is no external dose model for the organ of interest and the organ is in proximity to the thyroid. The 

thyroid has higher organ dose conversion factors than the remainder selection, which maximizes the 

dose. If a more realistic dose assessment is required rather than a maximizing dose assessment, the 

remainder organ should be selected to calculate dose. 

4.4 REMAINDER SELECTION FOR EXTERNAL DOSE

If there are cancers of multiple organs or the cancer site is unknown, the remainder organ should be 

selected as the model to apply dose. However, if the organ location can be determined through the 

medical records or a medical review, an organ in physical proximity should be selected. The 

remainder selection provides an estimate of dose that is favorable to the claimant. 

4.5 BLADDER

If Table 3-1 lists “Bladder” with no modifier, this represents the urinary bladder. If the organ of interest 

is the gallbladder, “Gallbladder” is specified clearly.

4.6 MULTIPLE IREP MODELS

If Table 3-1 lists multiple IREP models for a given cancer type, the IREP model(s) to be run is 

determined based on the use of the words “OR” and “AND” in the IREP Model column.

For multiple IREP models that are connected by “OR”, only the model that best fits the actual cancer 

type should be selected and run in IREP. For example, ICD-9 code 173.0 is listed as “Non-melanoma 
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 9 of 42

skin-Basal cell OR Non-melanoma skin-Squamous cell” in the IREP Model column. The appropriate 

IREP model would be selected and run based on the type of skin cancer (basal cell or squamous cell) 

that is listed in the claim’s NIOSH Referral Summary Document.

For multiple IREP models that are connected by the word “AND”, separate IREP runs should be made 

for each listed model, and compensability is determined based on the model that results in the highest 

POC, which is favorable to the claimant. For example, ICD-9 code 233.3 is listed as “Female genitalia 

less ovary AND Ovary” in the IREP Model column. Separate IREP runs should be made using each 

model, and compensability would be based on the model that results in the highest POC.

4.7 SKIN CANCER MODEL CLARIFICATION

If the IREP Model column lists “Non-melanoma skin-basal cell OR Non-melanoma skin-squamous 

cell”, and the skin cancer is named but not clearly as squamous or basal, the non-melanoma 

squamous cell model is to be used. This model was developed with all named, non-melanoma, nonbasal cell carcinomas included.

For example, for ICD-9 code 173, if the named cancer is fibrosarcoma of skin, this is not clearly either 

squamous cell or basal cell carcinoma. It is a specific, named cancer, however, so the nonmelanoma squamous cell model should be used (rather than using both models and selecting the 

higher POC).

The only exceptions to this rule are the named cancers basalsquamous cell carcinoma and 

squamobasal cell carcinoma. Because these are transitional forms, both IREP models should be run 

and the one that yields the larger POC should be selected.

In 2011, the ICD-9 code information for 173 (skin cancers) was updated to reflect a 5th digit (NCHS 

2011). The 5th digit now clarifies the type of skin cancer, if known. The 5th digits represent the 

following:

0 = Unspecified type of cancer – compare BCC and SCC

1 = Basal cell – Use BCC

2 = Squamous cell – use SCC

9 = Other specified – use SCC unless specified as basalsquamous cell carcinoma or 

squamobasal cell carcinoma (see direction above)

4.8 ADENOCARCINOMA OF THE DISTAL (LOWER THIRD) ESOPHAGUS

If adenocarcinoma is indicated in the distal esophagus (also known as the lower third, abdominal, 

lower thoracic esophagus, gastroesophageal, cardioesophageal junction, or esophageal cardia), the 

appropriate IMBA, external, and IREP organ model is the stomach. To use the stomach model, both

conditions must be met (adenocarcinoma AND correct location). If either condition is not met, the use 

of the esophagus for the IMBA, external, and IREP organ model is appropriate.

Although applicable to other ICD-9 codes as well, a brief discussion of the abbreviations “nec” and 

“nos” is given here with application to ICD-9 code 150.

NEC: Not Elsewhere Classified - This designation is used to indicate that there is no separate 

specific code available to represent the condition documented. In this case, the diagnostic 

statement is specific, but the coding system is not specific enough.
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 10 of 42

NOS: Not Otherwise Specified - This designation is equivalent to the word "unspecified" and 

indicates that the documentation does not provide enough information to assign a more 

specific code. 

The general impact of these two terms is that “nec” is used when information is known but the coding 

cannot be specific enough and “nos” is used when there is not enough information about the 

cancer/cancer site. In the case of ICD-9 code 150.8 (Malig neo esophagus nec) this means that the 

site appears to be known but is not classified by the other extensions. This is taken to mean that it 

may overlap locations, so both esophagus and stomach are viable options and both models should be 

run unless there is clear information in the file of a single location. In the case of 150.9 (Malig neo 

esophagus nos), the site is not known, thus the conditions discussed above (adenocarcinoma AND 

correct location) cannot be met.

4.9 SECONDARY CANCERS – LIKELY PRIMARY CANCER SITES WITH MULTIPLE IMBA, 

EXTERNAL, AND IREP ORGAN MODEL OPTIONS

For secondary cancers with unknown primary cancer sites, the likely primary cancer sites are listed in 

Table 3-2. Because the likely primary cancer sites are listed only by ICD-9 code (three-digit code 

with no extensions), it is possible for a single likely primary cancer site to have multiple options for 

IMBA, external, and IREP organ model selection. In this case, each possible option must be 

assessed, and the option that yields the largest POC should be submitted.

For example, secondary cancer code 196.2 has a likely primary cancer site of ICD-9 code 189. ICD-9 

code 189 has an Internal Dosimetry Organ selection of kidney, highest nonmetabolic organ, and 

bladder, depending on the extension of the ICD-9 code. Because it is an unknown location, each of 

these organs must be run for internal dose purposes, and the one yielding the largest dose over the 

exposure period should be selected for use in the IREP run.

A special case of this also arises for secondary cancer code 196.2, which has another likely primary 

cancer site of ICD-9 code 153. ICD-9 code 153 has an Internal Dosimetry Organ selection of upper 

large intestine (ULI), lower large intestine (LLI), and colon, depending on the extension of the ICD-9 

code. Normally, each of these organs would be run for internal dose purposes, and the one yielding 

the largest dose over the exposure period should be selected for use in the IREP run.

To facilitate the dose reconstruction process, a comparison of all nuclide/type combinations available 

in the CAD tool was made for ULI and LLI (Brackett, 2011). For the majority of nuclides, the LLI is 

more claimant favorable than the ULI. The exceptions are noted below.

ULI yields a larger dose for: I-133

I-134

I-135

Mn-56

Na-24

Pa-234

Se-75

Te-131

The comparison of ULI and LLI was inconclusive for the following radionuclides, so both need to be 

run and compared: Eu-152

Eu-154

Ac-227 (Type F only)

Ag-100m (Type F only)
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 11 of 42

For all remaining individual nuclide/type combinations in the CAD tool, the lower large intestine (LLI) 

yields an equal or larger dose than the ULI. Therefore, ULI calculations do not need to be run for 

them.

Additionally, since the colon is a weighted average of the ULI and LLI, the colon does not need to be 

run at all for comparison since the ULI or LLI will always be greater than an average of the two.

4.10 MULTIPLE SECONDARY CANCERS WITH UNKNOWN PRIMARY CANCER SITE OR 

MULTIPLE PRIMARY AND SECONDARY CANCERS

In some claims, multiple secondary cancers with unknown primary cancer locations might be 

indicated. In such cases, unless DOL specifically states differently, each likely primary cancer site 

from each secondary cancer is to be treated separately, with individual IREP POC determinations,

and combined as separate primary cancers.

For example, consider a claim that has indicated separate secondary cancers of 196.0 (Lymph nodes 

of head, face, and neck) and 197.7 (Liver, specified as secondary), with no indication of the cancers 

being metastasized from a single unknown primary cancer site. When each of the likely primary 

cancer sites is assessed, ICD-9 code 162 (Lung) yields the largest POC for each at 38% (for this 

example only). Because it is possible that each secondary cancer came from a separate likely 

primary lung cancer, the POC results for each likely primary lung cancer should be combined to yield 

a final POC of 61.56% (per multiple cancer calculation in IREP).

The same type of situation might occur when primary and secondary cancers are both indicated by 

DOL. The same logic applies that, unless specifically directed otherwise by DOL, each cancer should 

be treated as a separate cancer for the determination of POC and for combining them for the final 

POC. It should not be assumed by the dose reconstructor that any listed secondary cancer has 

metastasized from another listed primary cancer.

4.11 CHRONIC LYMPHOCYTIC LEUKEMIA

Chronic lymphocytic leukemia (CLL) originates in the B lymphocytes rather than in a well-defined 

organ as with other cancers. These lymphocytes are distributed throughout the lymph system and 

can travel throughout the body with their inventories in various compartments of the body changing

significantly with age, gender, health status and other factors. Estimation of dose to the cancer site 

for CLL cases requires the calculation of the radiation dose to this population of CLL precursor cells. 

This is more complex than dose assessment to other cancer sites because CLL precursor cells can 

be present in different compartments of the lymphatic system throughout the body, and these 

compartments can receive substantially different doses.

Due to the complicated modeling needed for CLL, a specific organ is not defined in Table 3-1. The 

methodology of assessing internal and external doses to various organs in the model is given in 

ORAUT-OTIB-0082 (ORAUT, 2012). When referring to the organ of interest in the dose 

reconstruction, the term “B lymphocytes” should be used. 
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 12 of 42

Table 3-1. Selection of organs, tissues, and IREP models for internal and external dose reconstruction based on ICD-9 code.

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

140 Malig neoplasm lip 

140.0 Malig neo upper vermilion Highest non-met org/tiss Skin Oral cav and pharynx

140.1 Malig neo lower vermilion Highest non-met org/tiss Skin Oral cav and pharynx

140.3 Malig neo upper lip, inner Highest non-met org/tiss Skin Oral cav and pharynx

140.4 Malig neo lower lip, inner Highest non-met org/tiss Skin Oral cav and pharynx

140.5 Malig neo lip, inner nos Highest non-met org/tiss Skin Oral cav and pharynx

140.6 Malig neo lip, commissure Highest non-met org/tiss Skin Oral cav and pharynx

140.8 Malig neo lip nec Highest non-met org/tiss Skin Oral cav and pharynx

140.9 Malig neo lip/vermil nos Highest non-met org/tiss Skin Oral cav and pharynx

141 Malig neo tongue 

141.0 Malig neo tongue base Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.1 Malig neo dorsal tongue Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.2 Malig neo tip/lat tongue Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.3 Malig neo ventral tongue Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.4 Malig neo ant 2/3 tongue Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.5 Malig neo tongue junction Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.6 Malig neo lingual tonsil LNET Thyroid/remaindera Oral cav and pharynx

141.8 Malig neo tongue nec Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

141.9 Malig neo tongue nos Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

142 Malig neo major salivary 

142.0 Malig neo parotid Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

142.1 Malig neo submandibular Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

142.2 Malig neo sublingual Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

142.8 Malig neo maj salivary nec Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

142.9 Malig neo salivary nos Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

143 Malignant neoplasm gum 

143.0 Malig neo upper gum Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

143.1 Malig neo lower gum Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

143.8 Malig neo gum nec Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

143.9 Malig neo gum nos Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

144 Malig neo mouth floor 

144.0 Malig neo ant floor mouth Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

144.1 Malig neo lat floor mouth Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

144.8 Malig neo mouth floor nec Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

144.9 Malig neo mouth floor nos Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

145 Malig neo mouth nec/nos 

145.0 Malig neo cheek mucosa Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx

145.1 Malig neo mouth vestibule Highest non-met org/tiss Thyroid/remaindera Oral cav and pharynx
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 13 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

145.2 Malig neo hard palate Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

145.3 Malig neo soft palate Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

145.4 Malig neo uvula Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

145.5 Malig neo palate nos Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

145.6 Malig neo retromolar Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

145.8 Malig neo mouth nec Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

145.9 Malig neo mouth nos Highest non-met org/tiss Thyroid/remainder

a Oral cav and pharynx

146 Malig neo oropharynx 

146.0 Malig neo tonsil LNET Esophagus Oral cav and pharynx

146.1 Malig neo tonsillar fossa LNET Esophagus Oral cav and pharynx

146.2 Malig neo tonsil pillars LNET Esophagus Oral cav and pharynx

146.3 Malig neo vallecula ET2 Esophagus Oral cav and pharynx

146.4 Malig neo ant epiglottis ET2 Esophagus Oral cav and pharynx

146.5 Malig neo epiglottis junct ET2 Esophagus Oral cav and pharynx

146.6 Malig neo lat oropharynx ET2 Esophagus Oral cav and pharynx

146.7 Malig neo post oropharynx ET2 Esophagus Oral cav and pharynx

146.8 Malig neo oropharynx nec ET2 Esophagus Oral cav and pharynx

146.9 Malig neo oropharynx nos ET2 Esophagus Oral cav and pharynx

147 Malig neo nasopharynx 

147.0 Malig neo super nasopharyn ET2 Esophagus Oral cav and pharynx

147.1 Malig neo post nasopharynx ET2 Esophagus Oral cav and pharynx

147.2 Malig neo lat nasopharynx ET2 Esophagus Oral cav and pharynx

147.3 Malig neo ant nasopharynx ET2 Esophagus Oral cav and pharynx

147.8 Malig neo nasopharynx nec ET2 Esophagus Oral cav and pharynx

147.9 Malig neo nasopharynx nos ET2 Esophagus Oral cav and pharynx

148 Malig neo hypopharynx 

148.0 Malig neo postcricoid ET2 Esophagus Oral cav and pharynx

148.1 Malig neo pyriform sinus ET2 Esophagus Oral cav and pharynx

148.2 Malig neo aryepiglott fold ET2 Esophagus Oral cav and pharynx

148.3 Malig neo post hypopharynx ET2 Esophagus Oral cav and pharynx

148.8 Malig neo hypopharynx nec ET2 Esophagus Oral cav and pharynx

148.9 Malig neo hypopharynx nos ET2 Esophagus Oral cav and pharynx

149 Other malig oropharynx 

149.0 Malig neo pharynx nos ET2 Esophagus Oral cav and pharynx

149.1 Malig neo waldeyer’s ring LNET Esophagus Oral cav and pharynx

149.8 Malig neo oral/pharynx nec ET2 Esophagus Oral cav and pharynx

149.9 Malig neo orophryn ill-def ET2 Esophagus Oral cav and pharynx

150 Malig neo esophagus 

150.0 Malig neo cervical esophag Esophagus Esophagus Esophagus
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 14 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

150.1 Malig neo thoracic esophag Esophagus Esophagus Esophagus

150.2 Malig neo abdomin esophag Esophagus/stomach

f Esophagus/stomachf Esophagus/stomachf

150.3 Malig neo upper 3rd esoph Esophagus Esophagus Esophagus

150.4 Malig neo middle 3rd esoph Esophagus Esophagus Esophagus

150.5 Malig neo lower 3rd esoph Esophagus/stomach

f Esophagus/stomachf Esophagus/stomachf

150.8 Malig neo esophagus nec Esophagus/stomach

f Esophagus/stomachf Esophagus/stomachf

150.9 Malig neo esophagus nos Esophagus Esophagus Esophagus

151 Malignant neo stomach 

151.0 Malig neo stomach cardia Stomach Stomach Stomach

151.1 Malig neo pylorus Stomach Stomach Stomach

151.2 Malig neo pyloric antrum Stomach Stomach Stomach

151.3 Malig neo stomach fundus Stomach Stomach Stomach

151.4 Malig neo stomach body Stomach Stomach Stomach

151.5 Malig neo stom lesser curv Stomach Stomach Stomach

151.6 Malig neo stom great curv Stomach Stomach Stomach

151.8 Malig neo stomach nec Stomach Stomach Stomach

151.9 Malig neo stomach nos Stomach Stomach Stomach

152 Malig neo small bowel 

152.0 Malig neo duodenum SI Stomach All digestive

152.1 Malig neo jejunum SI Stomach All digestive

152.2 Malig neo ileum SI Stomach All digestive

152.3 Malig neo meckel’s divert SI Stomach All digestive

152.8 Malig neo small bowel nec SI Stomach All digestive

152.9 Malig neo small bowel nos SI Stomach All digestive

153 Malignant neoplasm colon 

153.0 Malig neo hepatic flexure ULI Colon Colon

153.1 Malig neo transverse colon ULI Colon Colon

153.2 Malig neo descend colon LLI Colon Colon

153.3 Malig neo sigmoid colon LLI Colon Colon

153.4 Malig neo cecum ULI Colon Colon

153.5 Malig neo appendix ULI Colon Colon

153.6 Malig neo ascend colon ULI Colon Colon

153.7 Malig neo splenic flexure LLI Colon Colon

153.8 Malig neo colon nec Colon Colon Colon

153.9 Malig neo colon nos Colon Colon Colon

154 Malig neo rectum/anus 

154.0 Malig neo rectosigmoid jct LLI Colon Rectum

154.1 Malig neo rectum LLI Colon Rectum

154.2 Malig neo anal canal LLI Colon Rectum
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 15 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

154.3 Malig neo anus nos LLI Colon Rectum

154.8 Malig neo rectum/anus nec LLI Colon Rectum

155 Malignant neoplasm liver 

155.0 Malig neo liver, primary Liver Liver Liver

155.1 Malig neo intrahepat ducts Liver/gallbladder

h Liver Gallbladder

155.2 Malig neo liver nos Liver Liver Liver

156 Malig neo gb/extrahepatic 

156.0 Malig neo gallbladder Gallbladder Liver Gallbladder

156.1 Malig neo extrahepat ducts Gallbladder Liver Gallbladder

156.2 Malig neo ampulla vater Gallbladder Liver Gallbladder

156.8 Malig neo biliary nec Gallbladder Liver Gallbladder

156.9 Malig neo biliary nos Gallbladder Liver Gallbladder

157 Malignant neo pancreas 

157.0 Malig neo pancreas head Pancreas Stomach Pancreas

157.1 Malig neo pancreas body Pancreas Stomach Pancreas

157.2 Malig neo pancreas tail Pancreas Stomach Pancreas

157.3 Malig neo pancreatic duct Pancreas Stomach Pancreas

157.4 Malig neo islet langerhans Pancreas Stomach Pancreas

157.8 Malig neo pancreas nec Pancreas Stomach Pancreas

157.9 Malig neo pancreas nos Pancreas Stomach Pancreas

158 Malig neo peritoneum 

158.0 Malig neo retroperitoneum Highest non-met org/tiss Stomach All digestive

158.8 Malig neo peritoneum nec Highest non-met org/tiss Stomach All digestive

158.9 Malig neo peritoneum nos Highest non-met org/tiss Stomach All digestive

159 Other malig neo gi/periton 

159.0 Malig neo intestine nos Colon Stomach All digestive

159.1 Malig neo spleen nec Spleen Stomach All digestive

159.8 Malig neo gi/intra-abd nec Highest non-met org/tiss Stomach All digestive

159.9 Malig neo gi tract ill-def Highest non-met org/tiss Stomach All digestive

160 Malig neo nasal cav/sinus 

160.0 Malig neo nasal cavities ET1 Thyroid/remainder

a Other respiratory

160.1 Malig neo middle ear Highest non-met org/tiss Thyroid/remainder

a Other respiratory

160.2 Malig neo maxillary sinus Highest non-met org/tiss Thyroid/remainder

a Other respiratory

160.3 Malig neo ethmoidal sinus Highest non-met org/tiss Thyroid/remainder

a Other respiratory

160.4 Malig neo frontal sinus Highest non-met org/tiss Thyroid/remainder

a Other respiratory

160.5 Malig neo sphenoid sinus Highest non-met org/tiss Thyroid/remainder

a Other respiratory

160.8 Malig neo access sinus nec Highest non-met org/tiss Thyroid/remainder

a Other respiratory

160.9 Malig neo access sinus nos Highest non-met org/tiss Thyroid/remainder

a Other respiratory

161 Malignant neo larynx 
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 16 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

161.0 Malig neo glottis ET2 Esophagus Other respiratory

161.1 Malig neo supraglottis ET2 Esophagus Other respiratory

161.2 Malig neo subglottis ET2 Esophagus Other respiratory

161.3 Malig neo cartilage larynx ET2 Esophagus Other respiratory

161.8 Malig neo larynx nec ET2 Esophagus Other respiratory

161.9 Malig neo larynx nos ET2 Esophagus Other respiratory

162 Malig neo trachea/lung 

162.0 Malig neo trachea Lung Lung Lung

162.2 Malig neo main bronchus Lung Lung Lung

162.3 Malig neo upper lobe lung Lung Lung Lung

162.4 Malig neo middle lobe lung Lung Lung Lung

162.5 Malig neo lower lobe lung Lung Lung Lung

162.8 Malig neo bronch/lung nec Lung Lung Lung

162.9 Malig neo bronch/lung nos Lung Lung Lung

163 Malignant neopl pleura 

163.0 Malig neo parietal pleura Highest non-met org/tiss Lung Other respiratory

163.1 Malig neo visceral pleura Highest non-met org/tiss Lung Other respiratory

163.8 Malig neo pleura nec Highest non-met org/tiss Lung Other respiratory

163.9 Malig neo pleura nos Highest non-met org/tiss Lung Other respiratory

164 Malig neo thymus/mediastin 

164.0 Malig neo thymus Thymus Thymus Other respiratory

164.1 Malig neo heart Heart Wall Thymus Other respiratory

164.2 Malig neo ant mediastinum Highest non-met org/tiss Thymus Other respiratory

164.3 Malig neo post mediastinum Highest non-met org/tiss Thymus Other respiratory

164.8 Malig neo mediastinum nec Highest non-met org/tiss Thymus Other respiratory

164.9 Malig neo mediastinum nos Highest non-met org/tiss Thymus Other respiratory

165 Oth/ill-def mal neo resp 

165.0 Malig neo upper resp nos Lung Lung Other respiratory

165.8 Malig neo thorax/resp nec Lung Lung Other respiratory

165.9 Malig neo resp system nos Lung Lung Other respiratory

170 Malig neo bone/artic cart 

170.0 Malig neo skull/face bone Bone surface Bone surface Bone

170.1 Malig neo mandible Bone surface Bone surface Bone

170.2 Malig neo vertebrae Bone surface Bone surface Bone

170.3 Malig neo ribs/stern/clav Medical review Bone surface Bone

170.4 Malig neo long bones arm Bone surface Bone surface Bone

170.5 Malig neo bones wrist/hand Bone surface Bone surface Bone

170.6 Malig neo pelvic girdle Medical review Bone surface Bone

170.7 Malig neo long bones leg Medical review Bone surface Bone
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 17 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

170.8 Malig neo bones ankle/foot Bone surface Bone surface Bone

170.9 Malig neo bone nos Medical review Bone surface Bone

171 Malig neo soft tissue 

171.0 Malig neo soft tissue head Highest non-met org/tiss Thyroid/remaindera Connective tissue

171.2 Malig neo soft tissue arm Highest non-met org/tiss Remainderb Connective tissue

171.3 Malig neo soft tissue leg Highest non-met org/tiss Remainderb Connective tissue

171.4 Malig neo soft tis thorax Highest non-met org/tiss Remainderb Connective tissue

171.5 Malig neo soft tis abdomen Highest non-met org/tiss Remainderb Connective tissue

171.6 Malig neo soft tis pelvis Highest non-met org/tiss Remainder

b Connective tissue

171.7 Malig neo trunk nos Highest non-met org/tiss Remainderb Connective tissue

171.8 Malig neo soft tissue nec Highest non-met org/tiss Remainderb Connective tissue

171.9 Malig neo soft tissue nos Highest non-met org/tiss Remainderb Connective tissue

172 Malignant melanoma skin 

172.0 Malig melanoma lip Skin Skin Malignant melanoma

172.1 Malig melanoma eyelid Skin Skin Malignant melanoma

172.2 Malig melanoma ear Skin Skin Malignant melanoma

172.3 Malig melanoma face nec/nos Skin Skin Malignant melanoma

172.4 Malig melanoma scalp/neck Skin Skin Malignant melanoma

172.5 Malig melanoma trunk Skin Skin Malignant melanoma

172.6 Malig melanoma arm Skin Skin Malignant melanoma

172.7 Malig melanoma leg Skin Skin Malignant melanoma

172.8 Malig melanoma skin nec Skin Skin Malignant melanoma

172.9 Malig melanoma skin nos Skin Skin Malignant melanoma

173 Other malig neopl skin 

173.0 Malig neo skin lip Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.00 Unspecified malig neo skin lip Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.01 BCC skin lip Skin Skin Non-melanoma skin-basal cell

173.02 SCC skin lip Skin Skin Non-melanoma skin-squamous

173.09 Other specified malig neo skin lip Skin Skin Non-melanoma skin-squamous celli

173.1 Malig neo eyelid Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.10 Unspecified malig neo eyelid Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.11 BCC skin eyelid Skin Skin Non-melanoma skin-basal cell

173.12 SCC skin eyelid Skin Skin Non-melanoma skin-squamous

173.19 Other specified malig neo eyelid Skin Skin Non-melanoma skin-squamous celli

173.2 Malig neo skin ear Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 18 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

173.20 Unspecified malig neo skin ear Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.21 BCC skin ear Skin Skin Non-melanoma skin-basal cell

173.22 SCC skin ear Skin Skin Non-melanoma skin-squamous

173.29 Other specified malig neo skin ear Skin Skin Non-melanoma skin-squamous celli

173.3 Malig neo skin face nec Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.30 Unspecified malig neo skin face nec Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.31 BCC skin face nec Skin Skin Non-melanoma skin-basal cell

173.32 SCC skin face nec Skin Skin Non-melanoma skin-squamous

173.39 Other specified malig neo skin face nec Skin Skin Non-melanoma skin-squamous celli

173.4 Malig neo scalp/skin neck Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.40 Unspecified malig neo scalp/skin neck Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.41 BCC skin scalp/skin neck Skin Skin Non-melanoma skin-basal cell

173.42 SCC skin scalp/skin neck Skin Skin Non-melanoma skin-squamous

173.49 Other specified malig neo scalp/skin neck Skin Skin Non-melanoma skin-squamous celli

173.5 Malig neo skin trunk Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.50 Unspecified malig neo skin trunk Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.51 BCC skin trunk Skin Skin Non-melanoma skin-basal cell

173.52 SCC skin trunk Skin Skin Non-melanoma skin-squamous

173.59 Other specified malig neo skin trunk Skin Skin Non-melanoma skin-squamous celli

173.6 Malig neo skin upper limb, incl shoulder Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.60 Unspecified malig neo skin upper limb, incl 

shoulder

Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.61 BCC skin upper limb, incl shoulder Skin Skin Non-melanoma skin-basal cell

173.62 SCC skin upper limb, incl shoulder Skin Skin Non-melanoma skin-squamous

173.69 Other specified malig neo skin upper limb, incl 

shoulder

Skin Skin Non-melanoma skin-squamous celli

173.7 Malig neo skin lower limb, incl hip Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.70 Unspecified malig neo skin lower limb, incl hip Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.71 BCC skin lower limb, incl hip Skin Skin Non-melanoma skin-basal cell
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 19 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

173.72 SCC skin lower limb, incl hip Skin Skin Non-melanoma skin-squamous

173.79 Other specified malig neo skin lower limb, incl 

hip

Skin Skin Non-melanoma skin-squamous celli

173.8 Malig neo skin nec Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.80 Unspecified malig neo skin nec Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.81 BCC skin nec Skin Skin Non-melanoma skin-basal cell

173.82 SCC skin nec Skin Skin Non-melanoma skin-squamous

173.89 Other specified malig neo skin nec Skin Skin Non-melanoma skin-squamous celli

173.9 Malig neo skin nos Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.90 Unspecified malig neo skin nos Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

173.91 BCC skin nos Skin Skin Non-melanoma skin-basal cell

173.92 SCC skin nos Skin Skin Non-melanoma skin-squamous

173.99 Other specified malig neo skin nos Skin Skin Non-melanoma skin-squamous celli

174 Malig neo female breast 

174.0 Malig neo nipple Breast Breast Breast

174.1 Malig neo breast-central Breast Breast Breast

174.2 Malig neo breast up-inner Breast Breast Breast

174.3 Malig neo breast low-inner Breast Breast Breast

174.4 Malig neo breast up-outer Breast Breast Breast

174.5 Malig neo breast low-outer Breast Breast Breast

174.6 Malig neo breast-axillary Breast Breast Breast

174.8 Malig neo breast nec Breast Breast Breast

174.9 Malig neo breast nos Breast Breast Breast

175 Malig neo male breast 

175.0 Malig neo male nipple Breast Breast Breast

175.9 Malig neo male breast nec Breast Breast Breast

176 Kaposi's sarcoma

176.0 Skin-kaposi's sarcoma Skin Skin Connective tissue AND

non-melanoma skin-squamous cell

176.1 Soft tissue-kaposi's sarcoma Highest non-met org/tiss Remainderb Connective tissue AND

non-melanoma skin-squamous cell

176.2 Palate-kaposi's sarcoma Highest non-met org/tiss Thyroid/remaindera Connective tissue AND

non-melanoma skin-squamous cell

176.3 Gi sites-kaposi's sarcoma Colon Stomach/colon

(location dependant)

Connective tissue AND

non-melanoma skin-squamous cell
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 20 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

176.4 Lung-kaposi's sarcoma Lung Lung Connective tissue AND

non-melanoma skin-squamous cell

176.5 Lymph nodes-kaposi's sarcoma Highest non-met org/tiss Remainder

b Connective tissue AND

non-melanoma skin-squamous cell

176.8 Spf sts-kaposi's sarcoma Highest non-met org/tiss Remainder

b Connective tissue AND

non-melanoma skin-squamous cell

176.9 Kaposi's sarcoma nos Highest non-met org/tiss Remainder

b Connective tissue AND

non-melanoma skin-squamous cell

179 Malig neo uterus nos Uterus Uterus Female genitalia less ovary

180 Malig neo cervix uteri 

180.0 Malig neo endocervix Uterus Uterus Female genitalia less ovary

180.1 Malig neo exocervix Uterus Uterus Female genitalia less ovary

180.8 Malig neo cervix nec Uterus Uterus Female genitalia less ovary

180.9 Malig neo cervix uteri nos Uterus Uterus Female genitalia less ovary

181 Malig neo placenta Uterus Uterus Female genitalia less ovary

182 Malig neo uterus body 

182.0 Malig neo corpus uteri Uterus Uterus Female genitalia less ovary

182.1 Malig neo uterine isthmus Uterus Uterus Female genitalia less ovary

182.8 Malig neo body uterus nec Uterus Uterus Female genitalia less ovary

183 Malig neo uterine adnexa 

183.0 Malig neo ovary Ovaries Ovaries Ovary

183.2 Malig neo fallopian tube Ovaries Ovaries Ovary

183.3 Malig neo broad ligament Ovaries Ovaries Ovary

183.4 Malig neo parametrium Uterus Ovaries Ovary

183.5 Malig neo round ligament Uterus Ovaries Ovary

183.8 Malig neo adnexa nec Ovaries Ovaries Ovary

183.9 Malig neo adnexa nos Ovaries Ovaries Ovary

184 Malig neo fem gen nec/nos 

184.0 Malig neo vagina Muscle Uterus Female genitalia less ovary

184.1 Malig neo labia majora Skin Uterus Female genitalia less ovary

184.2 Malig neo labia minora Skin Uterus Female genitalia less ovary

184.3 Malig neo clitoris Skin Uterus Female genitalia less ovary

184.4 Malig neo vulva nos Skin Uterus Female genitalia less ovary

184.8 Malig neo female genit nec Uterus Uterus Female genitalia less ovary

184.9 Malig neo female genit nos Uterus Uterus Female genitalia less ovary

185 Malig neo prostate Highest non-met org/tiss Bladder All male genitalia

186 Malig neo testis 

186.0 Malig neo undescend testis Testes Testes All male genitalia

186.9 Malig neo testis nec Testes Testes All male genitalia
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 21 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

187 Malig neo male genital nec 

187.1 Malig neo prepuce Skin Testes All male genitalia

187.2 Malig neo glans penis Skin Testes All male genitalia

187.3 Malig neo penis body Testes Testes All male genitalia

187.4 Malig neo penis nos Testes Testes All male genitalia

187.5 Malig neo epididymis Testes Testes All male genitalia

187.6 Malig neo spermatic cord Testes Testes All male genitalia

187.7 Malig neo scrotum Testes Testes All male genitalia

187.8 Malig neo male genital nec Testes Testes All male genitalia

187.9 Malig neo male genital nos Testes Testes All male genitalia

188 Malig neo bladder 

188.0 Malig neo bladder-trigone Bladder Bladder Bladder

188.1 Malig neo bladder-dome Bladder Bladder Bladder

188.2 Malig neo bladder-lateral Bladder Bladder Bladder

188.3 Malig neo bladder-anterior Bladder Bladder Bladder

188.4 Malig neo bladder-post Bladder Bladder Bladder

188.5 Malig neo bladder neck Bladder Bladder Bladder

188.6 Malig neo ureteric orifice Bladder Bladder Bladder

188.7 Malig neo urachus Bladder Bladder Bladder

188.8 Malig neo bladder nec Bladder Bladder Bladder

188.9 Malig neo bladder nos Bladder Bladder Bladder

189 Malig neo urinary nec/nos 

189.0 Malig neo kidney Kidney Liver Urinary organs less bladder

189.1 Malig neo renal pelvis Kidney Liver Urinary organs less bladder

189.2 Malig neo ureter Highest non-met org/tiss Liver Urinary organs less bladder

189.3 Malig neo urethra Highest non-met org/tiss Liver Urinary organs less bladder

189.4 Malig neo paraurethral Highest non-met org/tiss Liver Urinary organs less bladder

189.8 Malig neo urinary nec Bladder Liver Urinary organs less bladder

189.9 Malig neo urinary nos Medical review Liver Urinary organs less bladder

190 Malig neoplasm eye 

190.0 Malig neo eyeball Brain Eye lens Eye

190.1 Malig neo orbit Brain Eye lens Eye

190.2 Malig neo lacrimal gland Skin Eye lens Eye

190.3 Malig neo conjunctiva Skin Eye lens Eye

190.4 Malig neo cornea Skin Eye lens Eye

190.5 Malig neo retina Brain Eye lens Eye

190.6 Malig neo choroid Brain Eye lens Eye

190.7 Malig neo lacrimal duct Skin Eye lens Eye

190.8 Malig neo eye nec Skin Eye lens Eye
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 22 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

190.9 Malig neo eye nos Skin Eye lens Eye

191 Malig neoasm brain 

191.0 Malig neo cerebrum Brain Thyroid/remainder

a Nervous system

191.1 Malig neo frontal lobe Brain Thyroid/remainder

a Nervous system

191.2 Malig neo temporal lobe Brain Thyroid/remainder

a Nervous system

191.3 Malig neo parietal lobe Brain Thyroid/remainder

a Nervous system

191.4 Malig neo occipital lobe Brain Thyroid/remainder

a Nervous system

191.5 Malig neo cereb ventricle Brain Thyroid/remainder

a Nervous system

191.6 Malig neo cerebellum nos Brain Thyroid/remainder

a Nervous system

191.7 Malig neo brain stem Brain Thyroid/remainder

a Nervous system

191.8 Malig neo brain nec Brain Thyroid/remainder

a Nervous system

191.9 Malig neo brain nos Brain Thyroid/remainder

a Nervous system

192 Malig neo nerve nec/nos 

192.0 Malig neo cranial nerves Brain Thyroid/remainder

a Nervous system

192.1 Malig neo cerebral mening Brain Thyroid/remainder

a Nervous system

192.2 Malig neo spinal cord Brain Thyroid/remainder

a Nervous system

192.3 Malig neo spinal meninges Brain Thyroid/remainder

a Nervous system

192.8 Malig neo nervous syst nec Brain Thyroid/remainder

a Nervous system

192.9 Malig neo nervous syst nos Brain Thyroid/remainder

a Nervous system

193 Malig neo thyroid Thyroid Thyroid Thyroid

194 Malig neo other endocrine 

194.0 Malig neo adrenal Adrenals Thyroid/remainder

a Other endocrine glands

194.1 Malig neo parathyroid Thyroid Thyroid Other endocrine glands

194.3 Malig neo pituitary Brain Thyroid/remainder

a Other endocrine glands

194.4 Malig neo pineal gland Brain Thyroid/remainder

a Other endocrine glands

194.5 Malig neo carotid body Brain Thyroid Other endocrine glands

194.6 Malig neo paraganglia nec Brain Thyroid/remainder

a Other endocrine glands

194.8 Malig neo endocrine nec Medical review Remainder

b Other endocrine glands

194.9 Malig neo endocrine nos Medical review Remainder

b Other endocrine glands

195 Malig neo oth/ill-def site 

195.0 Malig neo head/face/neck Highest non-met org/tiss Thyroid/remainder

a Other and ill

-defined sites

195.1 Malig neo thorax Highest non-met org/tiss Remainder

b Other and ill

-defined sites

195.2 Malig neo abdomen Highest non-met org/tiss Remainder

b Other and ill

-defined sites

195.3 Malig neo pelvis Highest non-met org/tiss Remainder

b Other and ill

-defined sites

195.4 Malig neo arm Highest non-met org/tiss Remainder

b Other and ill

-defined sites

195.5 Malig neo leg Highest non-met org/tiss Remainder

b Other and ill

-defined sites

195.8 Malig neo site nec Highest non-met org/tiss Remainder

b Other and ill

-defined sites

196 Malig neo lymph nodes

196.0 Malig neo lymph-head/neck NA

c NAc NAc
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 23 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

196.1 Malig neo lymph-intrathor NA

c NAc NAc

196.2 Malig neo lymph-intra-abd NA

c NAc NAc

196.3 Malig neo lymph-axilla/arm NA

c NAc NAc

196.5 Malig neo lymph-inguin/leg NA

c NAc NAc

196.6 Malig neo lymph-intrapelv NA

c NAc NAc

196.8 Malig neo lymph-mult NA

c NAc NAc

196.9 Malig neo lymph nos NA

c NAc NAc

197 Sec malig neo gi/resp

197.0 Sec malig neo lung NA

c NAc NAc

197.1 Sec malig neo mediastinum NA

c NAc NAc

197.2 Sec malig neo pleura NA

c NAc NAc

197.3 Sec malig neo resp nec NA

c NAc NAc

197.4 Sec malig neo sm bowel NA

c NAc NAc

197.5 Sec malig neo lg bowel NA

c NAc NAc

197.6 Sec malig neo peritoneum NA

c NAc NAc

197.7 Sec malig neo liver NA

c NAc NAc

197.8 Sec malig neo gi nec NA

c NAc NAc

198 Sec malig neo other sites

198.0 Sec malig neo kidney NA

c NAc NAc

198.1 Sec malig neo urin nec NA

c NAc NAc

198.2 Sec malig neo skin NA

c NAc NAc

198.3 Sec malig neo brain/spine NA

c NAc NAc

198.4 Sec malig neo nerve nec NA

c NAc NAc

198.5 Sec malig neo bone NA

c NAc NAc

198.6 Sec malig neo ovary NA

c NAc NAc

198.7 Sec malig neo adrenal NA

c NAc NAc

198.8 Other secondary malig neo 

198.81 Sec malig neo breast NA

c NAc NAc

198.82 Sec malig neo genital NA

c NAc NAc

198.89 Sec malig neo nec NA

c NAc NAc

199

j Malig neoplasm nos

199.0

j Malig neo disseminated Highest non

-met org/tiss Remainder

b Other and ill

-defined sites

199.1

j Malig neo nos Highest non

-met org/tiss Remainder

b Other and ill

-defined sites

200 Lymphosarc/reticulosarc LN(TH) Thyroid Lymphoma and multiple myeloma

200.0 Reticulosarcoma LN(TH) Thyroid Lymphoma and multiple myeloma

200.00 Retclsrc unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

200.01 Reticulosarcoma head LN(ET) Thyroid Lymphoma and multiple myeloma

200.02 Reticulosarcoma thorax LN(TH) Lung Lymphoma and multiple myeloma

200.03 Reticulosarcoma abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 24 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

200.04 Reticulosarcoma axilla LN(TH) Lung Lymphoma and multiple myeloma

200.05 Reticulosarcoma inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.06 Reticulosarcoma pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.07 Reticulosarcoma spleen Spleen Stomach Lymphoma and multiple myeloma

200.08 Reticulosarcoma mult LN(TH) Thyroid Lymphoma and multiple myeloma

200.1 Lymphosarcoma LN(TH) Thyroid Lymphoma and multiple myeloma

200.10 Lymphsrc unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

200.11 Lymphosarcoma head LN(ET) Thyroid Lymphoma and multiple myeloma

200.12 Lymphosarcoma thorax LN(TH) Lung Lymphoma and multiple myeloma

200.13 Lymphosarcoma abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

200.14 Lymphosarcoma axilla LN(TH) Lung Lymphoma and multiple myeloma

200.15 Lymphosarcoma inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.16 Lymphosarcoma pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.17 Lymphosarcoma spleen Spleen Stomach Lymphoma and multiple myeloma

200.18 Lymphosarcoma mult LN(TH) Thyroid Lymphoma and multiple myeloma

200.2 Burkitt's tumor/lymphoma LN(TH) Lung Lymphoma and multiple myeloma

200.20 Burkitt's tumor unspec ext org LN(TH) Lung Lymphoma and multiple myeloma

200.21 Burkitt's tumor head LN(TH) Lung Lymphoma and multiple myeloma

200.22 Burkitt's tumor thorax LN(TH) Lung Lymphoma and multiple myeloma

200.23 Burkitt's tumor abdom LN(TH) Lung Lymphoma and multiple myeloma

200.24 Burkitt's tumor axilla LN(TH) Lung Lymphoma and multiple myeloma

200.25 Burkitt's tumor inguin LN(TH) Lung Lymphoma and multiple myeloma

200.26 Burkitt's tumor pelvic LN(TH) Lung Lymphoma and multiple myeloma

200.27 Burkitt's tumor spleen LN(TH) Lung Lymphoma and multiple myeloma

200.28 Burkitt's tumor mult LN(TH) Lung Lymphoma and multiple myeloma

200.30 Marg zone lymphomas unspec LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.31 Marg zone lymphomas head LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.32 Marg zone lymphomas thorax LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.33 Marg zone lymphomas abdom LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.34 Marg zone lymphomas axilla LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.35 Marg zone lymphomas inguin LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.36 Marg zone lymphomas pelvic LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.37 Marg zone lymphomas spleen LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.38 Marg zone lymphomas mult LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.40 Mantle cell lymphomas unspec LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.41 Mantle cell lymphomas head LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.42 Mantle cell lymphomas thorax LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.43 Mantle cell lymphomas abdom LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.44 Mantle cell lymphomas axilla LN(TH) Thymus/lung

g Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 25 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

200.45 Mantle cell lymphomas inguin LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.46 Mantle cell lymphomas pelvic LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.47 Mantle cell lymphomas spleen LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.48 Mantle cell lymphomas mult LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.50 Primary cns lymphomas unspec LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.51 Primary cns lymphomas head LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.52 Primary cns lymphomas thorax LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.53 Primary cns lymphomas abdom LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.54 Primary cns lymphomas axilla LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.55 Primary cns lymphomas inguin LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.56 Primary cns lymphomas pelvic LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.57 Primary cns lymphomas spleen LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.58 Primary cns lymphomas mult LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

200.60 Anaplas lg cell lymphomas unspec LN(TH) Thyroid Lymphoma and multiple myeloma

200.61 Anaplas lg cell lymphomas head LN(ET) Thyroid Lymphoma and multiple myeloma

200.62 Anaplas lg cell lymphomas thorax LN(TH) Lung Lymphoma and multiple myeloma

200.63 Anaplas lg cell lymphomas abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

200.64 Anaplas lg cell lymphomas axilla LN(TH) Lung Lymphoma and multiple myeloma

200.65 Anaplas lg cell lymphomas inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.66 Anaplas lg cell lymphomas pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.67 Anaplas lg cell lymphomas spleen Spleen Stomach Lymphoma and multiple myeloma

200.68 Anaplas lg cell lymphomas mult LN(TH) Thyroid Lymphoma and multiple myeloma

200.70 Lg cell lymphomas unspec LN(TH) Thyroid Lymphoma and multiple myeloma

200.71 Lg cell lymphomas head LN(ET) Thyroid Lymphoma and multiple myeloma

200.72 Lg cell lymphomas thorax LN(TH) Lung Lymphoma and multiple myeloma

200.73 Lg cell lymphomas abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

200.74 Lg cell lymphomas axilla LN(TH) Lung Lymphoma and multiple myeloma

200.75 Lg cell lymphomas inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.76 Lg cell lymphomas pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.77 Lg cell lymphomas spleen Spleen Stomach Lymphoma and multiple myeloma

200.78 Lg cell lymphomas mult LN(TH) Thyroid Lymphoma and multiple myeloma

200.8 Mixed lymphosarcoma LN(TH) Thyroid Lymphoma and multiple myeloma

200.80 Other varn unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

200.81 Mixed lymphosarc head LN(ET) Thyroid Lymphoma and multiple myeloma

200.82 Mixed lymphosarc thorax LN(TH) Lung Lymphoma and multiple myeloma

200.83 Mixed lymphosarc abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

200.84 Mixed lymphosarc axilla LN(TH) Lung Lymphoma and multiple myeloma

200.85 Mixed lymphosarc inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

200.86 Mixed lymphosarc pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 26 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

200.87 Mixed lymphosarc spleen Spleen Stomach Lymphoma and multiple myeloma

200.88 Mixed lymphosarc mult LN(TH) Thyroid Lymphoma and multiple myeloma

201 Hodgkin's disease LN(TH) Thyroid Lymphoma and multiple myeloma

201.0 Hodgkin's paragranuloma LN(TH) Thyroid Lymphoma and multiple myeloma

201.00 Hodgkins paragranuloma unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.01 Hodgkins paragran head LN(ET) Thyroid Lymphoma and multiple myeloma

201.02 Hodgkins paragran thorax LN(TH) Lung Lymphoma and multiple myeloma

201.03 Hodgkins paragran abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.04 Hodgkins paragran axilla LN(TH) Lung Lymphoma and multiple myeloma

201.05 Hodgkins paragran inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.06 Hodgkins paragran pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.07 Hodgkins paragran spleen Spleen Stomach Lymphoma and multiple myeloma

201.08 Hodgkins paragran mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.1 Hodgkin's granuloma LN(TH) Thyroid Lymphoma and multiple myeloma

201.10 Hodgkins granulom unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.11 Hodgkins granulom head LN(ET) Thyroid Lymphoma and multiple myeloma

201.12 Hodgkins granulom thorax LN(TH) Lung Lymphoma and multiple myeloma

201.13 Hodgkins granulom abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.14 Hodgkins granulom axilla LN(TH) Lung Lymphoma and multiple myeloma

201.15 Hodgkins granulom inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.16 Hodgkins granulom pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.17 Hodgkins granulom spleen Spleen Stomach Lymphoma and multiple myeloma

201.18 Hodgkins granulom mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.2 Hodgkin's sarcoma LN(TH) Thyroid Lymphoma and multiple myeloma

201.20 Hodgkins src unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.21 Hodgkins sarcoma head LN(ET) Thyroid Lymphoma and multiple myeloma

201.22 Hodgkins sarcoma thorax LN(TH) Lung Lymphoma and multiple myeloma

201.23 Hodgkins sarcoma abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.24 Hodgkins sarcoma axilla LN(TH) Lung Lymphoma and multiple myeloma

201.25 Hodgkins sarcoma inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.26 Hodgkins sarcoma pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.27 Hodgkins sarcoma spleen Spleen Stomach Lymphoma and multiple myeloma

201.28 Hodgkins sarcoma mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.4 Hodgkins lymph-histiocyt LN(TH) Thyroid Lymphoma and multiple myeloma

201.40 Lym-hst unspec ext orgn LN(TH) Thyroid Lymphoma and multiple myeloma

201.41 Hodgkins lymph-histio head LN(ET) Thyroid Lymphoma and multiple myeloma

201.42 Hodgkins lymph-histio thorax LN(TH) Lung Lymphoma and multiple myeloma

201.43 Hodgkins lymph-histio abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.44 Hodgkins lymph-histio axilla LN(TH) Lung Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 27 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

201.45 Hodgkins lymph-histio inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.46 Hodgkins lymph-histio pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.47 Hodgkins lymph-histio spleen Spleen Stomach Lymphoma and multiple myeloma

201.48 Hodgkins lymph-histio mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.5 Hodgkins nodular scleros LN(TH) Thyroid Lymphoma and multiple myeloma

201.50 Nodular scleros unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.51 Hodgkins nodul sclero head LN(ET) Thyroid Lymphoma and multiple myeloma

201.52 Hodgkins nodul sclero thorax LN(TH) Lung Lymphoma and multiple myeloma

201.53 Hodgkins nodul sclero abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.54 Hodgkins nodul sclero axilla LN(TH) Lung Lymphoma and multiple myeloma

201.55 Hodgkins nodul sclero inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.56 Hodgkins nodul sclero pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.57 Hodgkins nodul sclero spleen Spleen Stomach Lymphoma and multiple myeloma

201.58 Hodgkins nodul sclero mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.6 Hodgkins mix cellularity LN(TH) Thyroid Lymphoma and multiple myeloma

201.60 Mxd celr unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.61 Hodgkins mix cell head LN(ET) Thyroid Lymphoma and multiple myeloma

201.62 Hodgkins mix cell thorax LN(TH) Lung Lymphoma and multiple myeloma

201.63 Hodgkins mix cell abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.64 Hodgkins mix cell axilla LN(TH) Lung Lymphoma and multiple myeloma

201.65 Hodgkins mix cell inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.66 Hodgkins mix cell pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.67 Hodgkins mix cell spleen Spleen Stomach Lymphoma and multiple myeloma

201.68 Hodgkins mix cell mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.7 Hodg lymphocytic deplet Highest non-met org/tiss Thyroid Lymphoma and multiple myeloma

201.70 Lym dplt unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.71 Hodgkins lymph deplet head LN(ET) Thyroid Lymphoma and multiple myeloma

201.72 Hodgkins lymph deplet thorax LN(TH) Lung Lymphoma and multiple myeloma

201.73 Hodgkins lymph deplet abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

201.74 Hodgkins lymph deplet axilla LN(TH) Lung Lymphoma and multiple myeloma

201.75 Hodgkins lymph deplet inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.76 Hodgkins lymph deplet pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.77 Hodgkins lymph deplet spleen Spleen Stomach Lymphoma and multiple myeloma

201.78 Hodgkins lymph deplet mult LN(TH) Thyroid Lymphoma and multiple myeloma

201.9 Hodgkins disease nos LN(TH) Thyroid Lymphoma and multiple myeloma

201.90 Hdgk disease unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

201.91 Hodgkins disease nos head LN(ET) Thyroid Lymphoma and multiple myeloma

201.92 Hodgkins disease nos thorax LN(TH) Lung Lymphoma and multiple myeloma

201.93 Hodgkins disease nos abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 28 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

201.94 Hodgkins disease nos axilla LN(TH) Lung Lymphoma and multiple myeloma

201.95 Hodgkins disease nos inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.96 Hodgkins disease nos pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

201.97 Hodgkins disease nos spleen Spleen Stomach Lymphoma and multiple myeloma

201.98 Hodgkins disease nos mult LN(TH) Thyroid Lymphoma and multiple myeloma

202 Other malig neo lymph/histio LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.0 Nodular lymphoma LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.00 Ndlr lym unspec ext org LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.01 Nodular lymphoma head LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.02 Nodular lymphoma thorax LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.03 Nodular lymphoma abdom LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.04 Nodular lymphoma axilla LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.05 Nodular lymphoma inguin LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.06 Nodular lymphoma pelvic LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.07 Nodular lymphoma spleen LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.08 Nodular lymphoma mult LN(TH) Thymus/lung

g Lymphoma and multiple myeloma

202.1 Mycosis fungoides Skin Skin Lymphoma and multiple myeloma

202.10 Mycs fng unspec ext org Skin Skin Lymphoma and multiple myeloma

202.11 Mycosis fungoides head Skin Skin Lymphoma and multiple myeloma

202.12 Mycosis fungoides thorax Skin Skin Lymphoma and multiple myeloma

202.13 Mycosis fungoides abdom Skin Skin Lymphoma and multiple myeloma

202.14 Mycosis fungoides axilla Skin Skin Lymphoma and multiple myeloma

202.15 Mycosis fungoides inguin Skin Skin Lymphoma and multiple myeloma

202.16 Mycosis fungoides pelvic Skin Skin Lymphoma and multiple myeloma

202.17 Mycosis fungoides spleen Skin Skin Lymphoma and multiple myeloma

202.18 Mycosis fungoides mult Skin Skin Lymphoma and multiple myeloma

202.2 Sezary's disease Skin Skin Lymphoma and multiple myeloma

202.20 Szry disease unspec ext org Skin Skin Lymphoma and multiple myeloma

202.21 Sezary's disease head Skin Skin Lymphoma and multiple myeloma

202.22 Sezary's disease thorax Skin Skin Lymphoma and multiple myeloma

202.23 Sezary's disease abdom Skin Skin Lymphoma and multiple myeloma

202.24 Sezary's disease axilla Skin Skin Lymphoma and multiple myeloma

202.25 Sezary's disease inguin Skin Skin Lymphoma and multiple myeloma

202.26 Sezary's disease pelvic Skin Skin Lymphoma and multiple myeloma

202.27 Sezary's disease spleen Skin Skin Lymphoma and multiple myeloma

202.28 Sezary's disease mult Skin Skin Lymphoma and multiple myeloma

202.3 Malig histiocytosis LN(TH) Thyroid Lymphoma and multiple myeloma

202.30 Mlg hist unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

202.31 Malig histiocytosis head LN(ET) Thyroid Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 29 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

202.32 Malig histiocytosis thorax LN(TH) Lung Lymphoma and multiple myeloma

202.33 Malig histiocytosis abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

202.34 Malig histiocytosis axilla LN(TH) Lung Lymphoma and multiple myeloma

202.35 Malig histiocytosis inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

202.36 Malig histiocytosis pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

202.37 Malig histiocytosis spleen Spleen Stomach Lymphoma and multiple myeloma

202.38 Malig histiocytosis mult LN(TH) Thyroid Lymphoma and multiple myeloma

202.4 Leukem reticuloendothel Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.40 Lk rtctl unspec ext org Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.41 Hairy-cell leukem head Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.42 Hairy-cell leukem thorax Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.43 Hairy-cell leukem abdom Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.44 Hairy-cell leukem axilla Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.45 Hairy-cell leukem inguin Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.46 Hairy-cell leukem pelvic Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.47 Hairy-cell leukem spleen Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.48 Hairy-cell leukem mult Red bone marrow Red bone marrow Lymphoma and multiple myeloma

202.5 Letterer-siwe disease LN(TH) Skin Lymphoma and multiple myeloma

202.50 Ltr-siwe unspec ext org LN(TH) Skin Lymphoma and multiple myeloma

202.51 Letterer-siwe disease head LN(TH) Skin Lymphoma and multiple myeloma

202.52 Letterer-siwe disease thorax LN(TH) Skin Lymphoma and multiple myeloma

202.53 Letterer-siwe disease abdom LN(TH) Skin Lymphoma and multiple myeloma

202.54 Letterer-siwe disease axilla LN(TH) Skin Lymphoma and multiple myeloma

202.55 Letterer-siwe disease inguin LN(TH) Skin Lymphoma and multiple myeloma

202.56 Letterer-siwe disease pelvic LN(TH) Skin Lymphoma and multiple myeloma

202.57 Letterer-siwe disease spleen LN(TH) Skin Lymphoma and multiple myeloma

202.58 Letterer-siwe disease mult LN(TH) Skin Lymphoma and multiple myeloma

202.6 Malig mast cell tumors LN(TH) Thyroid Lymphoma and multiple myeloma

202.60 Malig mast unspec ext org LN(TH) Thyroid Lymphoma and multiple myeloma

202.61 Malig mastocytosis head LN(ET) Thyroid Lymphoma and multiple myeloma

202.62 Malig mastocytosis thorax LN(TH) Lung Lymphoma and multiple myeloma

202.63 Malig mastocytosis abdom Highest non-met org/tiss Stomach Lymphoma and multiple myeloma

202.64 Malig mastocytosis axilla LN(TH) Lung Lymphoma and multiple myeloma

202.65 Malig mastocytosis inguin Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

202.66 Malig mastocytosis pelvic Highest non-met org/tiss Bladder Lymphoma and multiple myeloma

202.67 Malig mastocytosis spleen Spleen Stomach Lymphoma and multiple myeloma

202.68 Malig mastocytosis mult LN(TH) Thyroid Lymphoma and multiple myeloma

202.7 Peripheral t cell (cutaneous) lymphoma unspec 

ext org Skin

Skin Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 30 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

202.70 Peripheral t cell (cutaneous) lymphoma unspec 

ext org Skin

Skin Lymphoma and multiple myeloma

202.71 Peripheral t cell (cutaneous) lymphoma head Skin Skin Lymphoma and multiple myeloma

202.72 Peripheral t cell (cutaneous) lymphoma thorax Skin Skin Lymphoma and multiple myeloma

202.73 Peripheral t cell (cutaneous) lymphoma abdom Skin Skin Lymphoma and multiple myeloma

202.74 Peripheral t cell (cutaneous) lymphoma axilla Skin Skin Lymphoma and multiple myeloma

202.75 Peripheral t cell (cutaneous) lymphoma inguin Skin Skin Lymphoma and multiple myeloma

202.76 Peripheral t cell (cutaneous) lymphoma pelvic Skin Skin Lymphoma and multiple myeloma

202.77 Peripheral t cell (cutaneous) lymphoma spleen Skin Skin Lymphoma and multiple myeloma

202.78 Peripheral t cell (cutaneous) lymphoma mult Skin Skin Lymphoma and multiple myeloma

202.8 Lymphomas nec LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.80 Other lymp unspec ext org LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.81 Lymphomas nec head LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.82 Lymphomas nec thorax LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.83 Lymphomas nec abdom LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.84 Lymphomas nec axilla LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.85 Lymphomas nec inguin LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.86 Lymphomas nec pelvic LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.87 Lymphomas nec spleen LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.88 Lymphomas nec mult LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.9 Malig neo lym/hist tis nec LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.90 Unspec lym unspec ext org LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.91 Lymphoid malig nec head LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.92 Lymphoid malig nec thorax LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.93 Lymphoid malig nec abdom LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.94 Lymphoid malig nec axilla LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.95 Lymphoid malig nec inguin LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.96 Lymphoid malig nec pelvic LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.97 Lymphoid malig nec spleen LN(TH) Thymus/lungg Lymphoma and multiple myeloma

202.98 Lymphoid malig nec mult LN(TH) Thymus/lungg Lymphoma and multiple myeloma

203 Multiple myeloma et al Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.0 Multiple myeloma Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.00 Mult myelm w/o remission Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.01 Mult myelm w/remission Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.02 Mult myelm in relapse Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.1 Plasma cell leukemia Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.10 Plsm cell leuk w/o remisson Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.11 Plsm cell leuk w/remiss Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.12 Plsm cell leuk in relapse Red bone marrow Red bone marrow Lymphoma and multiple myeloma
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 31 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

203.8 Immunoproliferat neoplasm nec Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.80 Other imnprfl npl w/o remiss Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.81 Other imnprfl npl w/remiss Red bone marrow Red bone marrow Lymphoma and multiple myeloma

203.82 Other imnprfl npl in relapse Red bone marrow Red bone marrow Lymphoma and multiple myeloma

204 Lymphoid leukemia Red bone marrow Red bone marrow Acute lymphoid leukemia

204.0 Acute lymphoid leukemia Red bone marrow Red bone marrow Acute lymphoid leukemia

204.00 Act lym leuk w/o remiss Red bone marrow Red bone marrow Acute lymphoid leukemia

204.01 Act lym leuk w/remiss Red bone marrow Red bone marrow Acute lymphoid leukemia

204.02 Act lym leuk in relapse Red bone marrow Red bone marrow Acute lymphoid leukemia

204.1 Chronic lymphoid leukemia Special

d Speciald Chronic lymphocytic leukemia

204.10 Chronic lym leuk w/o remiss Special

d Speciald Chronic lymphocytic leukemia

204.11 Chronic lym leuk w/remiss Special

d Speciald Chronic lymphocytic leukemia

204.12 Chronic lym leuk in relapse Special

d Speciald Chronic lymphocytic leukemia

204.2 Subacute lymphoid leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

204.20 Sbac lym leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

204.21 Sbac lym leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

204.22 Sbac lym leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

204.8 Lymphoid leukemia nec Red bone marrow Red bone marrow Leukemia, excl. CLL

204.80 Other lym leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

204.81 Other lym leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

204.82 Other lym leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

204.9 Lymphoid leukemia nos Red bone marrow Red bone marrow Acute lymphoid leukemia

204.90 Uns lym leuk w/o remiss Red bone marrow Red bone marrow Acute lymphoid leukemia

204.91 Uns lym leuk w/remiss Red bone marrow Red bone marrow Acute lymphoid leukemia

204.92 Uns lym leuk in relapse Red bone marrow Red bone marrow Acute lymphoid leukemia

205 Myeloid leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.0 Acute myeloid leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.00 Act myl leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.01 Act myl leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.02 Act myl leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.1 Chronic myeloid leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia

205.10 Chronic myl leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 32 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

205.11 Chronic myl leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia

205.12 Chronic myl leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia

205.2 Subacut myeloid leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

205.20 Sbac myl leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

205.21 Sbac myl leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

205.22 Sbac myl leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

205.3 Myeloid sarcoma Red bone marrow Red bone marrow Leukemia, excl. CLL

205.30 Myl srcoma w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

205.31 Myl srcoma w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

205.32 Myl srcoma in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

205.8 Myeloid leukemia nec Red bone marrow Red bone marrow Leukemia, excl. CLL

205.80 Other myl leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

205.81 Other myl leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

205.82 Other myl leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

205.9 Myeloid leukemia nos Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.90 Uns myl leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.91 Uns myl leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

205.92 Uns myl leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute myeloid leukemia

206 Monocytic leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

206.0 Acute monocytic leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

206.00 Act mono leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.01 Act mono leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.02 Act mono leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

206.1 Chronic monocytic leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

206.10 Chronic mono leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.11 Chronic mono leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.12 Chronic mono leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

206.2 Subac monocytic leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

206.20 Sbacute mono leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.21 Sbacute mono leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.22 Sbacute mono leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

206.8 Monocytic leukemia nec Red bone marrow Red bone marrow Leukemia, excl. CLL

206.80 Other mono leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 33 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

206.81 Other mono leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.82 Other mono leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

206.9 Monocytic leukemia nos Red bone marrow Red bone marrow Leukemia, excl. CLL

206.90 Uns mono leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.91 Uns mono leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

206.92 Uns mono leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

207 Other specified leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

207.0 Acute erythremia Red bone marrow Red bone marrow Leukemia, excl. CLL

207.00 Act erth/erylk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

207.01 Act erth/erylk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

207.02 Act erth/erylk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

207.1 Chronic erythremia Red bone marrow Red bone marrow Leukemia, excl. CLL

207.10 Chronic erythrm w/o remision Red bone marrow Red bone marrow Leukemia, excl. CLL

207.11 Chronic erythrm w/remision Red bone marrow Red bone marrow Leukemia, excl. CLL

207.12 Chronic erythrm in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

207.2 Megakaryocytic leukemia Red bone marrow Red bone marrow Leukemia, excl. CLL

207.20 Mgkrycyt leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

207.21 Mgkrycyt leuk w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

207.22 Mgkrycyt leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

207.8 Specified leukemia nec Red bone marrow Red bone marrow Leukemia, excl. CLL

207.80 Other spf leuk w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL

207.81 Other spf leuk w/remsion Red bone marrow Red bone marrow Leukemia, excl. CLL

207.82 Other spf leuk in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

208 Leukemia-unspecif cell Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia

208.0 Act leuk uns cl w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia

208.00 Act leuk uns cl w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia

208.01 Act leuk uns cl w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia

208.02 Act leuk uns cl in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 34 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

208.1 Chronic leukemia nos Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia

208.10 Chronic leuk uns cl w/o remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

Chronic myeloid leukemia

208.11 Chronic leuk uns cl w/remiss Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia

208.12 Chronic leuk uns cl in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL AND

chronic myeloid leukemia

208.2 Subacute leukemia nos Red bone marrow Red bone marrow Leukemia, excl. CLL

208.20 Subacute leukemia uns cl w/o remission Red bone marrow Red bone marrow Leukemia, excl. CLL

208.21 Subacute leukemia uns cl w/remission Red bone marrow Red bone marrow Leukemia, excl. CLL

208.22 Subacute leukemia uns cl in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

208.8 Leukemia-unspec cell nec Red bone marrow Red bone marrow Leukemia, excl. CLL

208.80 Other leuk uns cl w/o remission Red bone marrow Red bone marrow Leukemia, excl. CLL

208.81 Other leuk uns cl w/remission Red bone marrow Red bone marrow Leukemia, excl. CLL

208.82 Other leuk uns cl in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL

208.9 Leukemia-unspec cell nos Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND 

acute myeloid leukemia AND

chronic myeloid leukemia

208.90 Other leuk nos w/o remission Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia AND

chronic myeloid leukemia

208.91 Other leuk nos w/remission Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia AND

chronic myeloid leukemia

208.92 Other leuk nos in relapse Red bone marrow Red bone marrow Leukemia, excl. CLL AND

acute lymphoid leukemia AND

acute myeloid leukemia AND

chronic myeloid leukemia

209.00 Malig carc tumor si, unspec SI Stomach All digestive

209.01 Malig carc tumor duodenum SI Stomach All digestive

209.02 Malig carc tumor jejunum SI Stomach All digestive

209.03 Malig carc tumor ileum SI Stomach All digestive

209.10 Malig carc tumor li, unspec Colon Colon Colon

209.11 Malig carc tumor appendix ULI Colon Colon

209.12 Malig carc tumor cecum ULI Colon Colon

209.13 Malig carc tumor ascend colon ULI Colon Colon
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 35 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

209.14 Malig carc tumor trans colon ULI Colon Colon

209.15 Malig carc tumor decend colon LLI Colon Colon

209.16 Malig carc tumor sig colon LLI Colon Colon

209.17 Malig carc tumor rectum LLI Colon Rectum

209.20 Malig carc tumor unknown site Highest non-met org/tiss Remainderb Other and ill-defined sites

209.21 Malig carc tumor lung Lung Lung Lung

209.22 Malig carc tumor thymus Thymus Thymus Other respiratory

209.23 Malig carc tumor stomach Stomach Stomach Stomach

209.24 Malig carc tumor kidney Kidney Liver Urinary organs less bladder

209.25 Malig carc tumor foregut, unspec Highest non-met org/tiss Remainderb Other and ill-defined sites

209.26 Malig carc tumor midgut, unspec Highest non-met org/tiss Remainderb Other and ill-defined sites

209.27 Malig carc tumor hindgut, unspec Highest non-met org/tiss Remainderb Other and ill-defined sites

209.29 Malig carc tumor other sites Highest non-met org/tiss Remainderb Other and ill-defined sites

209.30 Malig poor diff neuroend carc, any site Highest non-met org/tiss Remainderb Other and ill-defined sites

209.31 Merkle cell carc face Skin Skin Non-melanoma skin-squamous cell

209.32 Merkle cell carc scalp/neck Skin Skin Non-melanoma skin-squamous cell

209.33 Merkle cell carc upper limb Skin Skin Non-melanoma skin-squamous cell

209.34 Merkle cell carc lower limb Skin Skin Non-melanoma skin-squamous cell

209.35 Merkle cell carc trunk Skin Skin Non-melanoma skin-squamous cell

209.36 Merkle cell carc other sites Skin Skin Non-melanoma skin-squamous cell

230 Ca in situ digestive org 

230.0 Ca in situ oral cav/phar Highest non-met org/tiss Thyroid Oral cav. and pharynx

230.1 Ca in situ esophagus Esophagus Esophagus Esophagus

230.2 Ca in situ stomach Stomach Stomach Stomach

230.3 Ca in situ colon Colon Colon Colon

230.4 Ca in situ rectum LLI Colon Rectum

230.5 Ca in situ anal canal LLI Colon Rectum

230.6 Ca in situ anus nos LLI Colon Rectum

230.7 Ca in situ bowel nec/nos Colon Colon All digestive

230.8 Ca in situ liver/biliary Liver Liver Liver

230.9 Ca in situ gi nec/nos Highest non-met org/tiss Remainderb All digestive

231 Ca in situ respiratory 

231.0 Ca in situ larynx ET2 Esophagus Other respiratory

231.1 Ca in situ trachea BB Thyroid Lung

231.2 Ca in situ bronchus/lung Lung Lung Lung

231.8 Ca in situ resp sys nec Medical review Medical review Other respiratory

231.9 Ca in situ resp sys nos Lung Lung Other respiratory

232 Carcinoma in situ skin 
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 36 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

232.0 Ca in situ skin lip Skin Skin Malignant melanoma AND non-

melanoma skin-basal Cell AND

non-melanoma skin-squamous cell

e

232.1 Ca in situ eyelid Skin Skin Malignant melanoma AND

Non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.2 Ca in situ skin ear Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.3 Ca in situ skin face nec Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.4 Ca in situ scalp Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.5 Ca in situ skin trunk Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.6 Ca in situ skin arm Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.7 Ca in situ skin leg Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

232.8 Ca in situ skin nec Skin Skin Malignant melanoma AND

non-melanoma skin-basal Cell AND

non-melanoma skin-squamous cell

e

232.9 Ca in situ skin nos Skin Skin Malignant melanoma AND

non-melanoma skin-basal cell AND

non-melanoma skin-squamous cell

e

233 Ca in situ breast/gu 

233.0 Ca in situ breast Breast Breast Breast

233.1 Ca in situ cervix uteri Uterus Uterus Female genitalia less ovary

233.2 Ca in situ uterus nec Uterus Uterus Female genitalia less ovary

233.3 Ca in situ fem gen nec Uterus Uterus Female genitalia less ovary AND 

ovary

233.30 Ca in situ fem gen unspec Uterus Uterus Female genitalia less ovary AND 

ovary

233.31 Ca in situ vagina Uterus Uterus Female genitalia less ovary AND 

ovary
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 37 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

233.32 Ca in situ vulva Skin Uterus Female genitalia less ovary AND 

ovary

233.39 Ca in situ other fem gen Uterus Uterus Female genitalia less ovary AND 

ovary

233.4 Ca in situ prostate Highest non-met org/tiss Bladder All male genitalia

233.5 Ca in situ penis Testes Testes All male genitalia

233.6 Ca in situ male gen nec Testes Testes All male genitalia

233.7 Ca in situ bladder Bladder Bladder Bladder

233.9 Ca in situ urinary nec Medical review Liver Urinary organs less bladder

234 Ca in situ nec/nos 

234.0 Ca in situ eye Brain Eye lens Eye

234.8 Ca in situ nec Highest non-met org/tiss Remainderb Other and ill-defined sites

234.9 Ca in situ nos Highest non-met org/tiss Remainderb Other and ill-defined sites

235 Uncert behav neoplasm gi/resp 

235.0 Uncert behav neoplasm salivary Highest non-met org/tiss Thyroid/remaindera Oral cav. and pharynx

235.1 Uncert behav neoplasm oral/phar Highest non-met org/tiss Thyroid/remaindera Oral cav. and pharynx

235.2 Uncert behav neoplasm intestine (stomach) Stomach Stomach Stomach

235.2 Uncert behav neoplasm intestine (colon) Colon Colon Colon

235.2 Uncert behav neoplasm intestine (rectum) LLI Colon Rectum

235.3 Uncert behav neoplasm liver Liver Liver Liver

235.4 Uncert behav neoplasm peritoneum Highest non-met org/tiss Colon All digestive

235.5 Uncert behav neoplasm gi nec Colon Colon All digestive

235.6 Uncert behav neoplasm larynx ET2 Esophagus Other respiratory

235.7 Uncert behav neoplasm lung Lung Lung Lung

235.8 Uncert behav neoplasm pleura Medical review Lung Other respiratory

235.9 Uncert behav neoplasm resp nec Medical review Lung Other respiratory

236 Uncert behav neoplasm gu 

236.0 Uncert behav neoplasm uterus Uterus Uterus Female genitalia, less ovary

236.1 Uncert behav neoplasm placenta Uterus Uterus Female genitalia, less ovary

236.2 Uncert behav neoplasm ovary Ovaries Ovaries Ovary

236.3 Uncert behav neoplasm female nec Medical review Uterus Female genitalia, less ovary

236.4 Uncert behav neoplasm testis Testes Testes All male genitalia

236.5 Uncert behav neoplasm prostate Highest non-met org/tiss Bladder All male genitalia

236.6 Uncert behav neoplasm male nec Testes Testes All male genitalia

236.7 Uncert behav neoplasm bladder Bladder Bladder Bladder

236.9 Uncert behav neoplasm other urinar Medical review Liver Urinary organs less bladder

236.90 Uncert behav neoplasm urinar nos Medical review Liver Urinary organs less bladder

236.91 Uncert behav neoplasm kidney Kidney Liver Urinary organs less bladder

236.99 Uncert behav neoplasm urinar nec Medical review Liver Urinary organs less bladder
Document No. ORAUT-OTIB-0005 Revision No. 05 Effective Date: 12/20/2012 Page 38 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

237 Uncer neoplasm endocrine/nerv 

237.0 Uncert behav neoplasm pituitary Brain Thyroid/remainder

a Thyroid

237.1 Uncert behav neoplasm pineal Brain Thyroid/remainder

a Thyroid

237.2 Uncert behav neoplasm adrenal Adrenal Liver Urinary organs less bladder

237.3 Uncert behav neoplasm paragang Brain Thyroid/remainder

a Nervous system

237.4 Uncer neoplasm endocrine nec Medical review Remainder

b Thyroid

237.5 Uncert beh neoplasm brain/spinal Brain Thyroid/remainder

a Nervous system

237.6 Uncert behav neoplasm meninges Brain Thyroid/remainder

a Nervous system

237.7 Neurofibromatosis Medical review Remainder

b Nervous system

237.70 Neurofibromatosis nos Medical review Remainder

b Nervous system

237.71 Neurofibromatosis type i Medical review Remainder

b Nervous system

237.72 Neurofibromatosis typ ii Medical review Remainder

b Nervous system

237.9 Uncert beh neoplasm nerv sys nec Medical review Remainder

b Nervous system

238 Uncert behav neoplasm nec/nos 

238.0 Uncert behav neoplasm bone Bone surface Bone surface Bone

238.1 Uncert behav neoplasm soft tissu Medical review Remainder

b Connective tissue

238.2 Uncert behav neoplasm skin Skin Skin Malignant melanoma AND Non-melanoma skin-basal cell AND Non-melanoma skin-squamous celle

238.3 Uncert behav neoplasm breast Breast Breast Breast

238.4 Polycythemia Red bone marrow Red bone marrow Bone

238.5 Mastocytoma nos Red bone marrow Red bone marrow Lymphoma and multiple myeloma

238.6 Plasmacytoma nos Red bone marrow Red bone marrow Lymphoma and multiple myeloma

238.7 Lymphoproliferat disease nos Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.71 Ess thrombocythemia Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.72 Lowgrade myelodyspl synd Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.73 Highgrade myelodyspl synd Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.74 Hmyelodyspl synd w/5q del Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.75 Myelodyspl synd, unspec Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.76 Myelofibrosis w/myeloid meta Red bone marrow Red bone marrow Bone AND

lymphoma and multiple myeloma

238.79 Other lymphatic/hematop tiss Red bone marrow Red bone marrow Bone AND

Lymphoma and multiple myeloma

238.8 Uncert behavior neoplasm nec Medical review Remainder

b Other and ill

-defined sites
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 39 of 42

ICD-9 

code Cancer code explanation Internal organ External organ IREP model

238.9 Uncert behavior neoplasm nos Medical review Remainderb Other and ill-defined sites

239 Unspecified neoplasm 

239.0 Digestive neoplasm nos Medical review Stomach All digestive

239.1 Respiratory neoplasm nos Medical review Lung Lung AND

other respiratory

239.2 Bone/skin neoplasm nos (bone) Bone surface Bone surface Bone

239.2 Bone/skin neoplasm nos (skin) Skin Skin Non-melanoma skin-basal cell OR

Non-melanoma skin-squamous celli

239.3 Breast neoplasm nos Breast Breast Breast

239.4 Bladder neoplasm nos Bladder Bladder Bladder

239.5 Other gu neoplasm nos (female) Medical review Bladder Female genitalia less ovary AND

ovary AND

all urinary organs

239.5 Other gu neoplasm nos (male) Medical review Testes All male genitalia AND

all urinary organs

239.6 Brain neoplasm nos Brain Thyroid/remaindera Nervous system

239.7 Brain/nerv neoplasm nos Medical review Remainderb Nervous system

239.7 Endocrine nos Medical review Remainderb Thyroid AND

other endocrine glands

239.8 Neoplasm nos, site nec Medical review Remainderb Other and ill-defined sites

239.81 Neoplasm nos, retina/choroid Medical review Remainderb Other and ill-defined sites

239.89 Neoplasm nos, other spec sites Medical review Remainderb Other and ill-defined sites

239.9 Neoplasm nos Medical review Remainderb Other and ill-defined sites

258.02 Multiple endocrine neo [men] type IIA Thyroid Thyroid Thyroid

273 Disorders of plasma protein metabolism

273.3 Waldenstrom's macroglobulinemia Red bone marrow Red bone marrow Lymphoma and multiple myeloma

289 Other specified blood disorder

289.7 Essential thrombocytosis Red bone marrow Red bone marrow Bone

289.8 Other specified diseases of blood and bloodforming organsRed bone marrow Red bone marrow Bone

289.81 Primary hypercoag state Red bone marrow Red bone marrow Bone

289.82 Secondary hypercoag state Red bone marrow Red bone marrow Bone

289.83 Myelofibrosis Red bone marrow Red bone marrow Bone

289.89 Unspecified diseases of blood and bloodforming organsRed bone marrow Red bone marrow Bone

289.9 Essential thrombocythemia Red bone marrow Red bone marrow Bone

a. See discussion in Section 4.3

b. See discussion in Section 4.4

c. For secondary cancers, doses are assessed for the likely primary cancer site(s), which are selected using guidance in Table 3-2.

d. See discussion in Section 4.11
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 40 of 42

e. For ICD-9 codes 232 and 238.2, if the type of cancer is specified by DOL (“Malignant melanoma, Non-melanoma skin-Squamous cell, or Non-melanoma skin-Basal 

cell”), use only the specified IREP model (note that Bowen’s disease is another name for squamous cell carcinoma in situ). If the cancer is not specified, run all listed

IREP models as discussed in Section 4.6.

f. See discussion in Section 4.8

g. The external target organ should be lung if the lymphoma is known to be a B-cell variety, or thymus if the lymphoma is known to be a T-cell variety or if the variety is 

unknown.

h. For ICD-9 code 155.1, for cancers that are described as cancer of the intrahepatic ducts, select liver as the internal organ. For those that are described as 

gallbladder carcinoma, select gallbladder as the internal organ. If the description is unclear, a medical review should be conducted to determine the appropriate 

internal organ of interest. 

i. See discussion in Section 4.7

j. For ICD-9 codes 199, 199.0, and 199.1 see discussion in Section 3.2
Document No. ORAUT-OTIB-0005 Revision No. 0

5 Effective Date: 12/20/2012 Page 41 of 42

Table 3-2. Selection of primary cancer(s) for dose reconstruction from secondary cancer codes.

Secondary cancer ICD-9 code of likely primary cancersa,b,c

196.0 Lymph nodes of head, face, and neck 141, 142(M), 146(M), 149(F), 161(M), 162, 172, 173, 174(F), 193(F)

196.1 Intrathoracic lymph nodes 150(M), 162, 174(F)

196.2 Intra-abdominal lymph nodes 150(M), 151(M), 153, 157(F), 162, 174(F), 180(F), 185(M), 189, 202(F)

196.3 Lymph nodes of axilla and upper limb 162, 172, 174(F)

196.5 Inguinal and lower limb lymph nodes 154(M), 162, 172, 173(F), 187(M)

196.6 Intrapelvic lymph nodes 153(M), 154(F), 162(M), 180(F), 182(F), 185(M), 188

196.8 Lymph nodes of multiple sites 150(M), 151(M), 153(M), 162, 174(F)

196.9 Lymph nodes, site unspecified 150(M), 151, 153, 162, 172, 174(F), 185(M)

197.0 Lung 153, 162, 172(M), 174(F), 185(M), 188(M), 189

197.1 Mediastinum 150(M), 162, 174(F)

197.2 Pleura 150(M), 153(M), 162, 174(F), 183(F), 185(M), 189(M)

197.3 Other respiratory organs 150, 153(M), 161, 162, 173(M), 174(F), 185(M), 193(F)

197.4 Small intestine, including duodenum 152, 153, 157, 162, 171, 172(M), 174(F), 183(F), 189(M)

197.5 Large intestine and rectum 153, 154, 162, 174(F), 183(F), 185(M)

197.6 Retroperitoneum and peritoneum 151, 153, 154(M), 157, 162(M), 171, 174(F), 182(F), 183(F)

197.7 Liver, specified as secondary 151(M), 153, 154(M), 157, 162, 174(F)

197.8 Other digestive organs 150(M), 151, 153, 157, 162, 174(F), 185(M)

198.0 Kidney 153, 162, 174(F), 180(F), 185(M), 188, 189, 202(F)

198.1 Other urinary organs 153, 174(F), 180(F), 183(F), 185(M), 188, 189(F)

198.2 Skin 153, 162, 171(M), 172, 173(M), 174(F), 189(M)

198.3 Brain and spinal cord 162, 172(M), 174(F)

198.4 Other parts of nervous system 162, 172(M), 174(F), 185(M), 202

198.5 Bone and bone marrow 162, 174(F), 185(M)

198.6 Ovary 153(F), 174(F), 183(F)

198.7 Suprarenal gland 153(F), 162, 174(F)

198.8 Other specified sites 153, 162, 172(M), 174(F), 183(F), 185(M), 188(M)

511.81 Malignant pleural effusion 150(M), 153(M), 162, 174(F), 183(F), 185(M), 189(M)

789.51 Malignant acsites 151, 153, 154(M), 157, 162(M), 171, 174(F), 182(F), 183(F)

a. “M” indicates cancer site should be used for males only; “F” indicates cancer site should be used for females only.

b. For likely primary cancer sites that have multiple possible IMBA or external organs, see Section 4.9.

c. If “173” is indicated as a likely primary cancer, the “non-melanoma skin-basal cell (BCC)” model should be used.
Document No. ORAUT-OTIB-0005 Revision No. 05-C Effective Date: 12/20/2012 Page 42 of 42

REFERENCES

Brackett, E. M., 2011, Selection of ULI vs. LLI for Internal Dose Assessments, Oak Ridge Associated 

Universities Team, Oak Ridge, Tennessee, November 14. [SRDB Ref ID: 120076]

DHHS (U.S. Department of Health and Human Services), 2008, International Classification of 

Diseases, Ninth Revision, Clinical Modification, Centers for Medicare and Medicaid Services 

and National Center for Health Statistics, Hyattsville, Maryland, October 1,

http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm.

DHHS (U.S. Department of Health and Human Services), 2009, Conversion Table of New ICD-9-CM 

Codes, Centers for Medicare and Medicaid Services and National Center for Health Statistics, 

Hyattsville, Maryland, October. [SRDB Ref ID: 71531]

ICRP (International Commission on Radiological Protection), 1979, Limits for the Intake of 

Radionuclides by Workers, Part 1, Publication 30, Part 1, Pergamon Press, Oxford, England.

ICRP (International Commission on Radiological Protection), 1994, Human Respiratory Tract Model 

for Radiological Protection, Publication 66, Pergamon Press, Oxford, England.

NCHS (National Center for Health Statistics), 2011, ICD-9-CM Diagnosis Tabular Addenda, October 

1, 2011 (FY2012), U.S. Department of Health and Human Services, Centers for Disease 

Control and Prevention, Atlanta, Georgia. [SRDB Ref ID: 119179]

NIOSH (National Institute for Occupational Safety and Health), 2002, Internal Dose Reconstruction 

Implementation Guideline, OCAS-IG-002, Rev. 0, National Institute for Occupational Safety 

and Health, Office of Compensation Analysis and Support, Cincinnati, Ohio, August 1.

NIOSH (National Institute for Occupational Safety and Health), 2006, Selection for Internal and 

External Dosimetry Target Organs for Lymphatic/Hematopoietic Cancers, OCAS-TIB-0012, 

Rev. 1, Office of Compensation Analysis and Support, Cincinnati, Ohio, February 10.

ORAUT (Oak Ridge Associated Universities Team), 2005, Dose Reconstruction from Occupationally 

Related Diagnostic X-Ray Procedures, ORAUT-OTIB-0006, Rev. 03 PC-1, Oak Ridge, 

Tennessee, December 21.

ORAUT (Oak Ridge Associated Universities Team), 2012, Dose Reconstruction Method for Chronic 

Lymphocytic Leukemia, ORAUT-OTIB-0082, Rev. 00, Oak Ridge, Tennessee, December 4.

WHO (World Health Organization), 1977, International Classification of Diseases, Ninth Revision, 

World Health Assembly, Geneva, Switzerland.